ONTOLOGY REPORT - ANNOTATIONS
| Term: | bisphenol A |
|
| Accession: | CHEBI:33216
|
browse the term
|
| Definition: | A bisphenol that has formula C15H16O2. |
| Synonyms: | exact_synonym: | 4,4'-(propane-2,2-diyl)diphenol |
| | related_synonym: | 2,2-Bis(4-Hydroxyphenyl)propane; 2,2-Bis(p-hydroxyphenyl)propane; 2,2-Di(4-hydroxyphenyl)propane; 2,2-Di(4-phenylol)propane; 4,4'-(1-Methylethylidene)bisphenol; 4,4'-Bisphenol A; 4,4'-Isopropylidenediphenol; C15H16O2; CC(C)(c1ccc(O)cc1)c1ccc(O)cc1; InChI=1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3; InChIKey=IISBACLAFKSPIT-UHFFFAOYSA-N |
| | alt_id: | CHEBI:22900; CHEBI:31295; CHEBI:47094 |
| | xref_casrn: | 80-05-7 |
| | xref: | ChEBI:c0764 "UM-BBD compID"; ChEMBL:255592 "ChEMBL COMPOUND"; ChemIDplus:80-05-7 "CAS Registry Number"; DrugBank:DB06973 "DrugBank"; KEGG COMPOUND:80-05-7 "CAS Registry Number"; KEGG COMPOUND:C13624 "KEGG COMPOUND" |
| | xref_mesh: | MESH:C006780 |
| | xref: | NIST Chemistry WebBook:80-05-7 "CAS Registry Number"; Wikipedia:Bisphenol_A "Wikipedia" |
|
|
bisphenol A
|
| G |
Aacs |
acetoacetyl-CoA synthetase |
|
increases expression |
ISO |
12 |
32,206,863 |
32,250,583 |
RGD:6480464 |
CTD |
| G |
Abat |
4-aminobutyrate aminotransferase |
|
affects expression |
ISO |
10 |
7,040,725 |
7,137,154 |
RGD:6480464 |
CTD |
| G |
Abca1 |
ATP-binding cassette, subfamily A (ABC1), member 1 |
|
increases expression |
EXP |
5 |
70,493,357 |
70,583,729 |
RGD:6480464 |
CTD |
| G |
Abcb1a |
ATP-binding cassette, sub-family B (MDR/TAP), member 1A |
|
increases expression |
ISO |
4 |
21,709,855 |
21,796,628 |
RGD:6480464 |
CTD |
| G |
Abcc2 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 2 |
|
affects export |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Abcc9 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 9 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Abhd11 |
abhydrolase domain containing 11 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Abhd2 |
abhydrolase domain containing 2 |
|
increases expression |
ISO |
1 |
135,025,144 |
135,111,792 |
RGD:6480464 |
CTD |
| G |
Acaca |
acetyl-CoA carboxylase alpha |
|
increases expression |
ISO |
10 |
72,483,772 |
72,677,134 |
RGD:6480464 |
CTD |
| G |
Acaca |
acetyl-CoA carboxylase alpha |
|
increases expression |
EXP |
10 |
72,483,772 |
72,677,134 |
RGD:6480464 |
CTD |
| G |
Acacb |
acetyl-CoA carboxylase beta |
|
increases expression |
ISO |
12 |
43,388,679 |
43,492,993 |
RGD:6480464 |
CTD |
| G |
Acly |
ATP citrate lyase |
|
increases expression |
ISO |
10 |
89,420,934 |
89,471,398 |
RGD:6480464 |
CTD |
| G |
Acpp |
acid phosphatase, prostate |
|
decreases expression |
EXP |
8 |
109,354,381 |
109,400,296 |
RGD:6480464 |
CTD |
| G |
Actn3 |
actinin alpha 3 |
|
increases expression |
EXP |
1 |
207,475,569 |
207,492,267 |
RGD:6480464 |
CTD |
| G |
Acvr2b |
activin A receptor, type IIB |
|
decreases expression |
ISO |
8 |
124,364,330 |
124,395,748 |
RGD:6480464 |
CTD |
| G |
Acvr2b |
activin A receptor, type IIB |
|
multiple interactions |
ISO |
8 |
124,364,330 |
124,395,748 |
RGD:6480464 |
CTD |
| G |
Acyp2 |
acylphosphatase 2, muscle type |
|
increases expression |
ISO |
14 |
111,507,725 |
111,512,680 |
RGD:6480464 |
CTD |
| G |
Acyp2-ps1 |
acylphosphatase 2, muscle type, pseudogene 1 |
|
increases expression |
ISO |
14 |
111,836,252 |
111,836,724 |
RGD:6480464 |
CTD |
| G |
Adam17 |
ADAM metallopeptidase domain 17 |
|
increases expression |
ISO |
6 |
41,882,432 |
41,930,755 |
RGD:6480464 |
CTD |
| G |
Adam17 |
ADAM metallopeptidase domain 17 |
|
decreases expression |
ISO |
6 |
41,882,432 |
41,930,755 |
RGD:6480464 |
CTD |
| G |
Adamts9 |
ADAM metallopeptidase with thrombospondin type 1 motif, 9 |
|
increases expression |
ISO |
4 |
126,996,604 |
127,198,909 |
RGD:6480464 |
CTD |
| G |
Adar |
adenosine deaminase, RNA-specific |
|
affects expression |
ISO |
2 |
181,935,246 |
181,956,039 |
RGD:6480464 |
CTD |
| G |
Adcy7 |
adenylate cyclase 7 |
|
increases expression |
EXP |
19 |
20,051,639 |
20,073,861 |
RGD:6480464 |
CTD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
multiple interactions |
ISO |
11 |
79,908,291 |
79,911,065 |
RGD:6480464 |
CTD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
decreases secretion |
ISO |
11 |
79,908,291 |
79,911,065 |
RGD:6480464 |
CTD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
decreases expression |
ISO |
11 |
79,908,291 |
79,911,065 |
RGD:6480464 |
CTD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
increases expression |
EXP |
11 |
79,908,291 |
79,911,065 |
RGD:6480464 |
CTD |
| G |
Afp |
alpha-fetoprotein |
|
affects expression |
ISO |
14 |
19,092,563 |
19,110,728 |
RGD:6480464 |
CTD |
| G |
Agpat5 |
1-acylglycerol-3-phosphate O-acyltransferase 5 |
|
decreases expression |
ISO |
16 |
75,745,813 |
75,788,182 |
RGD:6480464 |
CTD |
| G |
Agr2 |
anterior gradient 2 homolog (Xenopus laevis) |
|
increases expression |
ISO |
6 |
54,695,633 |
54,716,858 |
RGD:6480464 |
CTD |
| G |
Agtpbp1 |
ATP/GTP binding protein 1 |
|
decreases expression |
ISO |
17 |
11,040,339 |
11,155,923 |
RGD:6480464 |
CTD |
| G |
Agtr1a |
angiotensin II receptor, type 1a |
|
decreases expression |
ISO |
17 |
40,629,318 |
40,684,982 |
RGD:6480464 |
CTD |
| G |
Agtrap |
angiotensin II receptor-associated protein |
|
increases expression |
ISO |
5 |
165,154,252 |
165,164,570 |
RGD:6480464 |
CTD |
| G |
Ahctf1 |
AT hook containing transcription factor 1 |
|
decreases expression |
ISO |
13 |
95,432,560 |
95,483,323 |
RGD:6480464 |
CTD |
| G |
Ahnak |
AHNAK nucleoprotein |
|
increases expression |
EXP |
1 |
211,662,523 |
211,692,558 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
affects activity |
ISO |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
increases expression |
ISO |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
multiple interactions |
ISO |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
increases expression |
EXP |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Ahrr |
aryl-hydrocarbon receptor repressor |
|
increases expression |
ISO |
1 |
29,797,025 |
29,894,912 |
RGD:6480464 |
CTD |
| G |
Aifm1 |
apoptosis-inducing factor, mitochondrion-associated 1 |
|
affects expression |
ISO |
X |
134,868,878 |
134,908,166 |
RGD:6480464 |
CTD |
| G |
Ak4 |
adenylate kinase 4 |
|
increases expression |
EXP |
5 |
122,062,872 |
122,119,335 |
RGD:6480464 |
CTD |
| G |
Akap12 |
A kinase (PRKA) anchor protein 12 |
|
decreases expression |
EXP |
1 |
34,979,039 |
35,068,763 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
increases expression |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
increases phosphorylation |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
increases phosphorylation |
EXP |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Alas1 |
aminolevulinate, delta-, synthase 1 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Alcam |
activated leukocyte cell adhesion molecule |
|
affects expression |
ISO |
11 |
49,424,243 |
49,630,071 |
RGD:6480464 |
CTD |
| G |
Aldh1a1 |
aldehyde dehydrogenase 1 family, member A1 |
|
affects expression |
ISO |
1 |
223,731,675 |
223,773,285 |
RGD:6480464 |
CTD |
| G |
Aldh3a1 |
aldehyde dehydrogenase 3 family, member A1 |
|
affects expression |
ISO |
10 |
47,365,195 |
47,374,880 |
RGD:6480464 |
CTD |
| G |
Aldh5a1 |
aldehyde dehydrogenase 5 family, member A1 |
|
increases expression |
EXP |
17 |
47,193,407 |
47,216,499 |
RGD:6480464 |
CTD |
| G |
Aldoa |
aldolase A, fructose-bisphosphate |
|
decreases expression |
EXP |
1 |
185,970,658 |
185,974,615 |
RGD:6480464 |
CTD |
| G |
Aldob |
aldolase B, fructose-bisphosphate |
|
increases expression |
ISO |
5 |
66,283,165 |
66,296,171 |
RGD:6480464 |
CTD |
| G |
Alpl |
alkaline phosphatase, liver/bone/kidney |
|
multiple interactions |
ISO |
5 |
156,501,739 |
156,558,727 |
RGD:6480464 |
CTD |
| G |
Alppl2 |
alkaline phosphatase, placental-like 2 |
|
increases expression |
ISO |
9 |
85,873,702 |
85,876,375 |
RGD:6480464 |
CTD |
| G |
Als2cr11 |
amyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 11 |
|
increases expression |
ISO |
9 |
57,611,478 |
57,657,977 |
RGD:6480464 |
CTD |
| G |
Amh |
anti-Mullerian hormone |
|
increases expression |
ISO |
7 |
10,417,325 |
10,419,673 |
RGD:6480464 |
CTD |
| G |
Anapc1 |
anaphase promoting complex subunit 1 |
|
increases expression |
ISO |
3 |
116,212,111 |
116,299,282 |
RGD:6480464 |
CTD |
| G |
Angptl7 |
angiopoietin-like 7 |
|
decreases expression |
ISO |
5 |
165,579,768 |
165,583,680 |
RGD:6480464 |
CTD |
| G |
Ankrd24 |
ankyrin repeat domain 24 |
|
decreases expression |
ISO |
7 |
9,534,366 |
9,554,062 |
RGD:6480464 |
CTD |
| G |
Ankrd40 |
ankyrin repeat domain 40 |
|
increases expression |
ISO |
10 |
82,977,241 |
82,985,181 |
RGD:6480464 |
CTD |
| G |
Ano1 |
anoctamin 1, calcium activated chloride channel |
|
increases expression |
ISO |
1 |
205,018,529 |
205,166,049 |
RGD:6480464 |
CTD |
| G |
Anxa2 |
annexin A2 |
|
increases expression |
ISO |
8 |
73,897,618 |
73,934,041 |
RGD:6480464 |
CTD |
| G |
Ap1s2 |
adaptor-related protein complex 1, sigma 2 subunit |
|
increases expression |
ISO |
X |
51,329,574 |
51,356,406 |
RGD:6480464 |
CTD |
| G |
Apaf1 |
apoptotic peptidase activating factor 1 |
|
decreases expression |
ISO |
7 |
27,932,908 |
28,020,533 |
RGD:6480464 |
CTD |
| G |
Apbb2 |
amyloid beta (A4) precursor protein-binding, family B, member 2 |
|
affects expression |
ISO |
14 |
44,197,568 |
44,526,047 |
RGD:6480464 |
CTD |
| G |
Apeh |
N-acylaminoacyl-peptide hydrolase |
|
increases expression |
EXP |
8 |
113,353,151 |
113,362,263 |
RGD:6480464 |
CTD |
| G |
Apex1 |
APEX nuclease (multifunctional DNA repair enzyme) 1 |
|
increases expression |
ISO |
15 |
26,904,124 |
26,906,224 |
RGD:6480464 |
CTD |
| G |
Aph1b |
anterior pharynx defective 1 homolog B (C. elegans) |
|
increases expression |
ISO |
8 |
71,122,681 |
71,143,726 |
RGD:6480464 |
CTD |
| G |
Apln |
apelin |
|
decreases expression |
EXP |
X |
134,387,285 |
134,396,762 |
RGD:6480464 |
CTD |
| G |
Apoa1 |
apolipoprotein A-I |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Apob |
apolipoprotein B |
|
increases expression |
EXP |
6 |
31,508,060 |
31,548,083 |
RGD:6480464 |
CTD |
| G |
Apobec3b |
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B |
|
increases expression |
ISO |
7 |
118,121,580 |
118,140,691 |
RGD:6480464 |
CTD |
| G |
Apoc1 |
apolipoprotein C-I |
|
decreases expression |
EXP |
1 |
78,996,677 |
78,999,960 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
decreases activity |
ISO |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
increases expression |
EXP |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
decreases activity |
ISO |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
affects binding |
ISO |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
multiple interactions |
ISO |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
multiple interactions |
ISO |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
multiple interactions |
ISO |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
decreases activity |
ISO |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
increases expression |
ISO |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
multiple interactions |
ISO |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
multiple interactions |
ISO |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
affects activity |
ISO |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Areg |
amphiregulin |
|
affects expression |
ISO |
14 |
18,466,313 |
18,475,571 |
RGD:6480464 |
CTD |
| G |
Arl8b |
ADP-ribosylation factor-like 8B |
|
decreases expression |
ISO |
4 |
144,299,366 |
144,344,431 |
RGD:6480464 |
CTD |
| G |
Arnt2 |
aryl hydrocarbon receptor nuclear translocator 2 |
|
multiple interactions |
ISO |
1 |
140,535,823 |
140,646,838 |
RGD:6480464 |
CTD |
| G |
Arnt2 |
aryl hydrocarbon receptor nuclear translocator 2 |
|
decreases expression |
ISO |
1 |
140,535,823 |
140,646,838 |
RGD:6480464 |
CTD |
| G |
Asip |
agouti signaling protein |
|
decreases methylation |
ISO |
3 |
145,445,175 |
145,536,831 |
RGD:6480464 |
CTD |
| G |
Asip |
agouti signaling protein |
|
multiple interactions |
ISO |
3 |
145,445,175 |
145,536,831 |
RGD:6480464 |
CTD |
| G |
Astn2 |
astrotactin 2 |
|
increases expression |
ISO |
5 |
82,124,461 |
83,128,927 |
RGD:6480464 |
CTD |
| G |
Atoh8 |
atonal homolog 8 (Drosophila) |
|
decreases expression |
ISO |
4 |
105,499,942 |
105,532,118 |
RGD:6480464 |
CTD |
| G |
Atp2b2 |
ATPase, Ca++ transporting, plasma membrane 2 |
|
increases expression |
ISO |
4 |
149,655,651 |
149,907,813 |
RGD:6480464 |
CTD |
| G |
Atp5o |
ATP synthase, H+ transporting, mitochondrial F1 complex, O subunit |
|
increases expression |
EXP |
11 |
31,914,320 |
31,920,632 |
RGD:6480464 |
CTD |
| G |
Aurka |
aurora kinase A |
|
increases expression |
ISO |
3 |
163,270,479 |
163,284,506 |
RGD:6480464 |
CTD |
| G |
Bad |
BCL2-associated agonist of cell death |
|
decreases expression |
ISO |
1 |
209,617,373 |
209,626,292 |
RGD:6480464 |
CTD |
| G |
Bak1 |
BCL2-antagonist/killer 1 |
|
decreases expression |
ISO |
20 |
5,255,954 |
5,264,593 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
decreases expression |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
increases expression |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
Bcl2-like 1 |
|
multiple interactions |
ISO |
3 |
143,129,087 |
143,180,199 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
Bcl2-like 1 |
|
increases expression |
ISO |
3 |
143,129,087 |
143,180,199 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
Bcl2-like 1 |
|
increases expression |
ISO |
3 |
143,129,087 |
143,180,199 |
RGD:6480464 |
CTD |
| G |
Bcl2l11 |
BCL2-like 11 (apoptosis facilitator) |
|
affects expression |
ISO |
3 |
115,692,323 |
115,722,701 |
RGD:6480464 |
CTD |
| G |
Bcl2l2 |
Bcl2-like 2 |
|
decreases expression |
ISO |
15 |
32,983,165 |
32,988,018 |
RGD:6480464 |
CTD |
| G |
Bik |
BCL2-interacting killer (apoptosis-inducing) |
|
affects expression |
ISO |
7 |
121,377,004 |
121,396,609 |
RGD:6480464 |
CTD |
| G |
Birc2 |
baculoviral IAP repeat-containing 2 |
|
affects expression |
ISO |
8 |
4,649,559 |
4,667,733 |
RGD:6480464 |
CTD |
| G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Blm |
Bloom syndrome, RecQ helicase-like |
|
increases expression |
ISO |
1 |
136,271,573 |
136,358,077 |
RGD:6480464 |
CTD |
| G |
Bok |
BCL2-related ovarian killer |
|
decreases expression |
ISO |
9 |
92,970,069 |
92,980,974 |
RGD:6480464 |
CTD |
| G |
Brca1 |
breast cancer 1, early onset |
|
increases methylation |
ISO |
10 |
90,513,630 |
90,572,676 |
RGD:6480464 |
CTD |
| G |
Bre |
brain and reproductive organ-expressed (TNFRSF1A modulator) |
|
affects expression |
ISO |
6 |
24,406,837 |
24,791,918 |
RGD:6480464 |
CTD |
| G |
C3 |
complement component 3 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
C3 |
complement component 3 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Cad |
carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase |
|
decreases expression |
ISO |
6 |
25,272,416 |
25,296,266 |
RGD:6480464 |
CTD |
| G |
Casp2 |
caspase 2 |
|
affects expression |
ISO |
4 |
70,029,728 |
70,047,164 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
decreases activity |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
decreases expression |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases expression |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases cleavage |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp6 |
caspase 6 |
|
decreases expression |
ISO |
2 |
227,361,538 |
227,373,844 |
RGD:6480464 |
CTD |
| G |
Casp7 |
caspase 7 |
|
decreases expression |
ISO |
1 |
262,689,300 |
262,721,591 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
decreases expression |
ISO |
9 |
57,389,353 |
57,437,803 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9, apoptosis-related cysteine peptidase |
|
increases expression |
ISO |
5 |
160,704,234 |
160,721,796 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
decreases activity |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
decreases activity |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cbs |
cystathionine beta synthase |
|
decreases expression |
ISO |
20 |
10,047,478 |
10,075,520 |
RGD:6480464 |
CTD |
| G |
Ccbp2 |
chemokine binding protein 2 |
|
decreases expression |
ISO |
8 |
127,026,528 |
127,028,214 |
RGD:6480464 |
CTD |
| G |
Ccdc146 |
coiled-coil domain containing 146 |
|
affects expression |
ISO |
4 |
9,233,108 |
9,304,850 |
RGD:6480464 |
CTD |
| G |
Ccdc69 |
coiled-coil domain containing 69 |
|
increases expression |
ISO |
10 |
40,456,241 |
40,482,835 |
RGD:6480464 |
CTD |
| G |
Ccdc77 |
coiled-coil domain containing 77 |
|
increases expression |
ISO |
4 |
156,704,407 |
156,726,949 |
RGD:6480464 |
CTD |
| G |
Ccdc79 |
coiled-coil domain containing 79 |
|
increases expression |
ISO |
19 |
411,789 |
469,013 |
RGD:6480464 |
CTD |
| G |
Ccdc93 |
coiled-coil domain containing 93 |
|
decreases expression |
ISO |
13 |
33,465,846 |
33,534,212 |
RGD:6480464 |
CTD |
| G |
Cckbr |
cholecystokinin B receptor |
|
increases expression |
ISO |
1 |
163,156,914 |
163,166,969 |
RGD:6480464 |
CTD |
| G |
Cckbr |
cholecystokinin B receptor |
|
multiple interactions |
ISO |
1 |
163,156,914 |
163,166,969 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
affects expression |
ISO |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccna1 |
cyclin A1 |
|
increases methylation |
ISO |
2 |
144,275,211 |
144,285,196 |
RGD:6480464 |
CTD |
| G |
Ccna2 |
cyclin A2 |
|
increases expression |
ISO |
2 |
123,062,752 |
123,069,085 |
RGD:6480464 |
CTD |
| G |
Ccna2 |
cyclin A2 |
|
affects expression |
ISO |
2 |
123,062,752 |
123,069,085 |
RGD:6480464 |
CTD |
| G |
Ccna2 |
cyclin A2 |
|
increases expression |
ISO |
2 |
123,062,752 |
123,069,085 |
RGD:6480464 |
CTD |
| G |
Ccnb1 |
cyclin B1 |
|
affects expression |
ISO |
2 |
31,574,600 |
31,581,784 |
RGD:6480464 |
CTD |
| G |
Ccnb1ip1 |
cyclin B1 interacting protein 1, E3 ubiquitin protein ligase |
|
decreases expression |
ISO |
15 |
26,771,098 |
26,786,775 |
RGD:6480464 |
CTD |
| G |
Ccnb2 |
cyclin B2 |
|
affects expression |
ISO |
8 |
74,892,108 |
74,906,181 |
RGD:6480464 |
CTD |
| G |
Ccnb2 |
cyclin B2 |
|
increases expression |
ISO |
8 |
74,892,108 |
74,906,181 |
RGD:6480464 |
CTD |
| G |
Ccnb2 |
cyclin B2 |
|
increases expression |
ISO |
8 |
74,892,108 |
74,906,181 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
affects expression |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
increases expression |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
increases expression |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
increases expression |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd3 |
cyclin D3 |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ccne2 |
cyclin E2 |
|
affects expression |
ISO |
5 |
25,032,748 |
25,044,509 |
RGD:6480464 |
CTD |
| G |
Ccnf |
cyclin F |
|
increases expression |
ISO |
10 |
13,474,659 |
13,500,979 |
RGD:6480464 |
CTD |
| G |
Ccni |
cyclin I |
|
affects expression |
ISO |
14 |
16,437,340 |
16,460,130 |
RGD:6480464 |
CTD |
| G |
Cd3d |
CD3 molecule, delta |
|
increases expression |
EXP |
8 |
47,932,151 |
47,936,744 |
RGD:6480464 |
CTD |
| G |
Cd44 |
Cd44 molecule |
|
decreases expression |
ISO |
3 |
88,022,962 |
88,110,352 |
RGD:6480464 |
CTD |
| G |
Cd44 |
Cd44 molecule |
|
increases expression |
ISO |
3 |
88,022,962 |
88,110,352 |
RGD:6480464 |
CTD |
| G |
Cd5 |
Cd5 molecule |
|
increases expression |
EXP |
1 |
213,213,327 |
213,234,277 |
RGD:6480464 |
CTD |
| G |
Cd53 |
Cd53 molecule |
|
increases expression |
EXP |
2 |
202,186,125 |
202,234,570 |
RGD:6480464 |
CTD |
| G |
Cd6 |
Cd6 molecule |
|
increases expression |
EXP |
1 |
213,290,835 |
213,329,594 |
RGD:6480464 |
CTD |
| G |
Cdc20 |
cell division cycle 20 |
|
increases expression |
ISO |
5 |
138,913,180 |
138,916,744 |
RGD:6480464 |
CTD |
| G |
Cdc45 |
cell division cycle 45 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cdc6 |
cell division cycle 6 |
|
increases expression |
ISO |
10 |
87,684,493 |
87,697,865 |
RGD:6480464 |
CTD |
| G |
Cdca8 |
cell division cycle associated 8 |
|
decreases expression |
ISO |
5 |
144,251,164 |
144,276,352 |
RGD:6480464 |
CTD |
| G |
Cdh2 |
cadherin 2 |
|
decreases expression |
EXP |
18 |
8,048,920 |
8,267,974 |
RGD:6480464 |
CTD |
| G |
Cdh6 |
cadherin 6 |
|
affects expression |
ISO |
2 |
62,547,961 |
62,703,034 |
RGD:6480464 |
CTD |
| G |
Cdh8 |
cadherin 8 |
|
affects expression |
ISO |
19 |
5,685,862 |
6,014,208 |
RGD:6480464 |
CTD |
| G |
Cdk1 |
cyclin-dependent kinase 1 |
|
increases expression |
ISO |
20 |
20,018,044 |
20,044,030 |
RGD:6480464 |
CTD |
| G |
Cdk1 |
cyclin-dependent kinase 1 |
|
increases expression |
ISO |
20 |
20,018,044 |
20,044,030 |
RGD:6480464 |
CTD |
| G |
Cdk10 |
cyclin-dependent kinase 10 |
|
affects expression |
ISO |
19 |
53,545,204 |
53,552,911 |
RGD:6480464 |
CTD |
| G |
Cdk2 |
cyclin dependent kinase 2 |
|
increases expression |
ISO |
7 |
2,000,196 |
2,007,682 |
RGD:6480464 |
CTD |
| G |
Cdk2ap2 |
cyclin-dependent kinase 2 associated protein 2 |
|
decreases expression |
ISO |
1 |
206,681,430 |
206,683,098 |
RGD:6480464 |
CTD |
| G |
Cdk4 |
cyclin-dependent kinase 4 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cdk4 |
cyclin-dependent kinase 4 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cdk5rap2 |
CDK5 regulatory subunit associated protein 2 |
|
decreases expression |
ISO |
5 |
87,564,010 |
87,738,257 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
decreases expression |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
affects expression |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
decreases expression |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
increases expression |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
increases expression |
EXP |
4 |
171,841,705 |
171,846,506 |
RGD:6480464 |
CTD |
| G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
increases expression |
ISO |
5 |
108,908,749 |
108,916,380 |
RGD:6480464 |
CTD |
| G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
increases methylation |
ISO |
5 |
108,908,749 |
108,916,380 |
RGD:6480464 |
CTD |
| G |
Cdkn2b |
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) |
|
increases expression |
ISO |
5 |
108,939,669 |
108,945,293 |
RGD:6480464 |
CTD |
| G |
Cdkn2c |
cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) |
|
decreases expression |
ISO |
5 |
131,012,524 |
131,017,679 |
RGD:6480464 |
CTD |
| G |
Cflar |
CASP8 and FADD-like apoptosis regulator |
|
affects expression |
ISO |
9 |
57,309,836 |
57,356,635 |
RGD:6480464 |
CTD |
| G |
Chd1l |
chromodomain helicase DNA binding protein 1-like |
|
increases expression |
ISO |
2 |
192,382,644 |
192,438,157 |
RGD:6480464 |
CTD |
| G |
Chrna4 |
cholinergic receptor, nicotinic, alpha 4 (neuronal) |
|
increases expression |
ISO |
3 |
170,171,214 |
170,185,998 |
RGD:6480464 |
CTD |
| G |
Cklf |
chemokine-like factor |
|
affects expression |
ISO |
19 |
655,880 |
665,215 |
RGD:6480464 |
CTD |
| G |
Cmtm4 |
CKLF-like MARVEL transmembrane domain containing 4 |
|
decreases expression |
ISO |
19 |
532,342 |
572,975 |
RGD:6480464 |
CTD |
| G |
Cradd |
CASP2 and RIPK1 domain containing adaptor with death domain |
|
decreases expression |
ISO |
7 |
32,504,279 |
32,517,581 |
RGD:6480464 |
CTD |
| G |
Creb1 |
cAMP responsive element binding protein 1 |
|
multiple interactions |
ISO |
9 |
63,170,785 |
63,234,727 |
RGD:6480464 |
CTD |
| G |
Crispld2 |
cysteine-rich secretory protein LCCL domain containing 2 |
|
increases expression |
EXP |
19 |
50,313,710 |
50,378,031 |
RGD:6480464 |
CTD |
| G |
Cs |
citrate synthase |
|
increases expression |
ISO |
7 |
1,626,181 |
1,652,197 |
RGD:6480464 |
CTD |
| G |
Csn2 |
casein beta |
|
decreases expression |
EXP |
14 |
21,847,981 |
21,855,216 |
RGD:6480464 |
CTD |
| G |
Cyb561a3 |
cytochrome b561 family, member A3 |
|
decreases expression |
ISO |
1 |
213,057,629 |
213,079,872 |
RGD:6480464 |
CTD |
| G |
Cyp11a1 |
cytochrome P450, family 11, subfamily a, polypeptide 1 |
|
decreases expression |
ISO |
8 |
61,793,976 |
61,805,308 |
RGD:6480464 |
CTD |
| G |
Cyp11a1 |
cytochrome P450, family 11, subfamily a, polypeptide 1 |
|
affects expression |
ISO |
8 |
61,793,976 |
61,805,308 |
RGD:6480464 |
CTD |
| G |
Cyp11a1 |
cytochrome P450, family 11, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
8 |
61,793,976 |
61,805,308 |
RGD:6480464 |
CTD |
| G |
Cyp17a1 |
cytochrome P450, family 17, subfamily a, polypeptide 1 |
|
decreases expression |
ISO |
1 |
251,965,458 |
251,971,449 |
RGD:6480464 |
CTD |
| G |
Cyp17a1 |
cytochrome P450, family 17, subfamily a, polypeptide 1 |
|
decreases expression |
EXP |
1 |
251,965,458 |
251,971,449 |
RGD:6480464 |
CTD |
| G |
Cyp17a1 |
cytochrome P450, family 17, subfamily a, polypeptide 1 |
|
decreases expression |
EXP |
1 |
251,965,458 |
251,971,449 |
RGD:6480464 |
CTD |
| G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
affects expression |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
decreases expression |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
affects expression |
ISO |
6 |
2,548,224 |
2,553,767 |
RGD:6480464 |
CTD |
| G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
increases expression |
ISO |
6 |
2,548,224 |
2,553,767 |
RGD:6480464 |
CTD |
| G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
decreases expression |
ISO |
6 |
2,548,224 |
2,553,767 |
RGD:6480464 |
CTD |
| G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
decreases expression |
EXP |
6 |
2,548,224 |
2,553,767 |
RGD:6480464 |
CTD |
| G |
Cyp2d3 |
cytochrome P450, family 2, subfamily d, polypeptide 3 |
|
multiple interactions |
ISO |
7 |
120,778,783 |
120,783,140 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
increases expression |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
multiple interactions |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
multiple interactions |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
multiple interactions |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
increases expression |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp4a3 |
cytochrome P450, family 4, subfamily a, polypeptide 3 |
|
decreases expression |
ISO |
5 |
135,876,140 |
135,893,753 |
RGD:6480464 |
CTD |
| G |
Cyp51 |
cytochrome P450, family 51 |
|
increases expression |
EXP |
4 |
26,752,677 |
26,771,131 |
RGD:6480464 |
CTD |
| G |
Cyp7a1 |
cytochrome P450, family 7, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
5 |
19,707,159 |
19,716,856 |
RGD:6480464 |
CTD |
| G |
Cyp7a1 |
cytochrome P450, family 7, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
5 |
19,707,159 |
19,716,856 |
RGD:6480464 |
CTD |
| G |
Cyr61 |
cysteine-rich, angiogenic inducer, 61 |
|
increases expression |
ISO |
2 |
243,824,303 |
243,827,262 |
RGD:6480464 |
CTD |
| G |
Derl2 |
Der1-like domain family, member 2 |
|
increases expression |
ISO |
10 |
57,911,784 |
57,921,221 |
RGD:6480464 |
CTD |
| G |
Dffa |
DNA fragmentation factor, alpha subunit |
|
decreases expression |
ISO |
5 |
166,179,130 |
166,192,029 |
RGD:6480464 |
CTD |
| G |
Dhcr7 |
7-dehydrocholesterol reductase |
|
affects expression |
ISO |
1 |
204,245,562 |
204,258,913 |
RGD:6480464 |
CTD |
| G |
Dhx29 |
DEAH (Asp-Glu-Ala-His) box polypeptide 29 |
|
increases expression |
ISO |
2 |
44,306,480 |
44,357,742 |
RGD:6480464 |
CTD |
| G |
Dmc1 |
DMC1 dosage suppressor of mck1 homolog, meiosis-specific homologous recombination (yeast) |
|
decreases expression |
ISO |
7 |
117,476,702 |
117,520,670 |
RGD:6480464 |
CTD |
| G |
Dnmt1 |
DNA (cytosine-5-)-methyltransferase 1 |
|
decreases expression |
ISO |
8 |
19,926,995 |
19,973,256 |
RGD:6480464 |
CTD |
| G |
Dnmt1 |
DNA (cytosine-5-)-methyltransferase 1 |
|
multiple interactions |
ISO |
8 |
19,926,995 |
19,973,256 |
RGD:6480464 |
CTD |
| G |
Dnmt3a |
DNA (cytosine-5-)-methyltransferase 3 alpha |
|
increases expression |
ISO |
6 |
26,802,612 |
26,878,878 |
RGD:6480464 |
CTD |
| G |
Dnmt3a |
DNA (cytosine-5-)-methyltransferase 3 alpha |
|
multiple interactions |
ISO |
6 |
26,802,612 |
26,878,878 |
RGD:6480464 |
CTD |
| G |
Dnmt3a |
DNA (cytosine-5-)-methyltransferase 3 alpha |
|
decreases expression |
ISO |
6 |
26,802,612 |
26,878,878 |
RGD:6480464 |
CTD |
| G |
Dnmt3a |
DNA (cytosine-5-)-methyltransferase 3 alpha |
|
increases expression |
EXP |
6 |
26,802,612 |
26,878,878 |
RGD:6480464 |
CTD |
| G |
Dnmt3a |
DNA (cytosine-5-)-methyltransferase 3 alpha |
|
increases expression |
EXP |
6 |
26,802,612 |
26,878,878 |
RGD:6480464 |
CTD |
| G |
Dnmt3b |
DNA (cytosine-5-)-methyltransferase 3 beta |
|
decreases expression |
ISO |
3 |
144,030,737 |
144,069,265 |
RGD:6480464 |
CTD |
| G |
Dnmt3b |
DNA (cytosine-5-)-methyltransferase 3 beta |
|
multiple interactions |
ISO |
3 |
144,030,737 |
144,069,265 |
RGD:6480464 |
CTD |
| G |
Dnmt3b |
DNA (cytosine-5-)-methyltransferase 3 beta |
|
increases expression |
EXP |
3 |
144,030,737 |
144,069,265 |
RGD:6480464 |
CTD |
| G |
Dnmt3b |
DNA (cytosine-5-)-methyltransferase 3 beta |
|
increases expression |
EXP |
3 |
144,030,737 |
144,069,265 |
RGD:6480464 |
CTD |
| G |
Dnmt3l |
DNA (cytosine-5-)-methyltransferase 3-like |
|
decreases expression |
ISO |
20 |
10,958,957 |
10,973,422 |
RGD:6480464 |
CTD |
| G |
Dnmt3l |
DNA (cytosine-5-)-methyltransferase 3-like |
|
multiple interactions |
ISO |
20 |
10,958,957 |
10,973,422 |
RGD:6480464 |
CTD |
| G |
E2f1 |
E2F transcription factor 1 |
|
increases expression |
ISO |
3 |
145,032,489 |
145,043,729 |
RGD:6480464 |
CTD |
| G |
E2f3 |
E2F transcription factor 3 |
|
increases expression |
ISO |
17 |
41,079,346 |
41,145,568 |
RGD:6480464 |
CTD |
| G |
E2f4 |
E2F transcription factor 4, p107/p130-binding |
|
affects expression |
ISO |
19 |
35,112,273 |
35,118,888 |
RGD:6480464 |
CTD |
| G |
E2f8 |
E2F transcription factor 8 |
|
decreases expression |
ISO |
1 |
98,640,381 |
98,694,764 |
RGD:6480464 |
CTD |
| G |
Eci2 |
enoyl-CoA delta isomerase 2 |
|
decreases expression |
ISO |
17 |
36,198,752 |
36,215,199 |
RGD:6480464 |
CTD |
| G |
Eea1 |
early endosome antigen 1 |
|
increases expression |
ISO |
7 |
33,294,184 |
33,396,666 |
RGD:6480464 |
CTD |
| G |
Egr3 |
early growth response 3 |
|
increases expression |
ISO |
15 |
50,477,453 |
50,479,909 |
RGD:6480464 |
CTD |
| G |
Eif2b1 |
eukaryotic translation initiation factor 2B, subunit 1 alpha |
|
affects expression |
ISO |
12 |
33,138,323 |
33,146,596 |
RGD:6480464 |
CTD |
| G |
Eif4b |
eukaryotic translation initiation factor 4B |
|
increases expression |
ISO |
7 |
140,814,663 |
140,836,485 |
RGD:6480464 |
CTD |
| G |
Eif4e |
eukaryotic translation initiation factor 4E |
|
increases expression |
ISO |
2 |
236,072,748 |
236,104,714 |
RGD:6480464 |
CTD |
| G |
Eif4e |
eukaryotic translation initiation factor 4E |
|
affects expression |
ISO |
2 |
236,072,748 |
236,104,714 |
RGD:6480464 |
CTD |
| G |
Eif4ebp1 |
eukaryotic translation initiation factor 4E binding protein 1 |
|
increases expression |
ISO |
16 |
69,110,522 |
69,123,895 |
RGD:6480464 |
CTD |
| G |
Eif4g2 |
eukaryotic translation initiation factor 4, gamma 2 |
|
increases expression |
ISO |
1 |
168,829,099 |
168,841,605 |
RGD:6480464 |
CTD |
| G |
Elovl5 |
ELOVL fatty acid elongase 5 |
|
increases expression |
ISO |
8 |
82,922,551 |
82,948,348 |
RGD:6480464 |
CTD |
| G |
Elovl6 |
ELOVL fatty acid elongase 6 |
|
increases expression |
ISO |
2 |
226,946,573 |
227,054,321 |
RGD:6480464 |
CTD |
| G |
Emx2 |
empty spiracles homeobox 2 |
|
increases expression |
EXP |
1 |
266,004,257 |
266,011,265 |
RGD:6480464 |
CTD |
| G |
Endog |
endonuclease G |
|
increases expression |
ISO |
3 |
9,184,023 |
9,187,524 |
RGD:6480464 |
CTD |
| G |
Erbb3 |
v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) |
|
increases expression |
EXP |
7 |
1,858,057 |
1,877,353 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
multiple interactions |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
affects binding |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
multiple interactions |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
decreases expression |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
decreases expression |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
multiple interactions |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
increases activity |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
increases expression |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
affects response to substance |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
multiple interactions |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
affects expression |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
affects localization |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
increases expression |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
increases expression |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
increases phosphorylation |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
affects expression |
EXP |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
affects localization |
EXP |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
decreases expression |
EXP |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
decreases expression |
EXP |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
increases activity |
EXP |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
increases expression |
EXP |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
increases methylation |
EXP |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
increases expression |
EXP |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
multiple interactions |
EXP |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
multiple interactions |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
multiple interactions |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
affects binding |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
multiple interactions |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
decreases expression |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
increases activity |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
affects activity |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
increases expression |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
increases expression |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
decreases expression |
EXP |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
decreases expression |
EXP |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
increases expression |
EXP |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
increases expression |
EXP |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
increases activity |
EXP |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
decreases expression |
EXP |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
decreases expression |
EXP |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
multiple interactions |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
affects binding |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
multiple interactions |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
multiple interactions |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
decreases expression |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
increases activity |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
increases expression |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
increases expression |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
multiple interactions |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
multiple interactions |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
affects expression |
EXP |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
affects expression |
EXP |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
multiple interactions |
EXP |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
affects binding |
EXP |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
multiple interactions |
EXP |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
multiple interactions |
EXP |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
decreases expression |
EXP |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
decreases expression |
EXP |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
increases activity |
EXP |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
increases expression |
EXP |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
increases expression |
EXP |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (ER beta) |
|
multiple interactions |
ISO |
6 |
98,691,167 |
98,775,299 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (ER beta) |
|
affects binding |
ISO |
6 |
98,691,167 |
98,775,299 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (ER beta) |
|
increases expression |
ISO |
6 |
98,691,167 |
98,775,299 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (ER beta) |
|
affects localization |
ISO |
6 |
98,691,167 |
98,775,299 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (ER beta) |
|
decreases expression |
ISO |
6 |
98,691,167 |
98,775,299 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (ER beta) |
|
increases expression |
ISO |
6 |
98,691,167 |
98,775,299 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (ER beta) |
|
increases expression |
ISO |
6 |
98,691,167 |
98,775,299 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (ER beta) |
|
multiple interactions |
ISO |
6 |
98,691,167 |
98,775,299 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (ER beta) |
|
affects localization |
EXP |
6 |
98,691,167 |
98,775,299 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (ER beta) |
|
increases activity |
EXP |
6 |
98,691,167 |
98,775,299 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (ER beta) |
|
decreases expression |
EXP |
6 |
98,691,167 |
98,775,299 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (ER beta) |
|
increases methylation |
EXP |
6 |
98,691,167 |
98,775,299 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (ER beta) |
|
increases expression |
EXP |
6 |
98,691,167 |
98,775,299 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (ER beta) |
|
multiple interactions |
EXP |
6 |
98,691,167 |
98,775,299 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (ER beta) |
|
multiple interactions |
ISO |
6 |
98,691,167 |
98,775,299 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (ER beta) |
|
multiple interactions |
ISO |
6 |
98,691,167 |
98,775,299 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (ER beta) |
|
affects binding |
ISO |
6 |
98,691,167 |
98,775,299 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (ER beta) |
|
increases expression |
ISO |
6 |
98,691,167 |
98,775,299 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (ER beta) |
|
decreases expression |
ISO |
6 |
98,691,167 |
98,775,299 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (ER beta) |
|
decreases expression |
EXP |
6 |
98,691,167 |
98,775,299 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (ER beta) |
|
multiple interactions |
ISO |
6 |
98,691,167 |
98,775,299 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (ER beta) |
|
multiple interactions |
ISO |
6 |
98,691,167 |
98,775,299 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (ER beta) |
|
multiple interactions |
ISO |
6 |
98,691,167 |
98,775,299 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (ER beta) |
|
multiple interactions |
ISO |
6 |
98,691,167 |
98,775,299 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (ER beta) |
|
multiple interactions |
ISO |
6 |
98,691,167 |
98,775,299 |
RGD:6480464 |
CTD |
| G |
Esrrg |
estrogen-related receptor gamma |
|
affects binding |
ISO |
13 |
103,794,661 |
104,405,301 |
RGD:6480464 |
CTD |
| G |
Esrrg |
estrogen-related receptor gamma |
|
increases expression |
ISO |
13 |
103,794,661 |
104,405,301 |
RGD:6480464 |
CTD |
| G |
Esrrg |
estrogen-related receptor gamma |
|
increases expression |
ISO |
13 |
103,794,661 |
104,405,301 |
RGD:6480464 |
CTD |
| G |
Esrrg |
estrogen-related receptor gamma |
|
increases response to substance |
EXP |
13 |
103,794,661 |
104,405,301 |
RGD:6480464 |
CTD |
| G |
Etl4 |
enhancer trap locus 4 |
|
increases expression |
ISO |
17 |
94,757,415 |
94,770,668 |
RGD:6480464 |
CTD |
| G |
Ext1 |
exostosin glycosyltransferase 1 |
|
increases expression |
ISO |
7 |
89,392,837 |
89,671,523 |
RGD:6480464 |
CTD |
| G |
F11r |
F11 receptor |
|
decreases expression |
ISO |
13 |
87,369,918 |
87,393,508 |
RGD:6480464 |
CTD |
| G |
F5 |
coagulation factor V (proaccelerin, labile factor) |
|
decreases expression |
ISO |
13 |
79,934,956 |
79,997,285 |
RGD:6480464 |
CTD |
| G |
Fabp4 |
fatty acid binding protein 4, adipocyte |
|
multiple interactions |
ISO |
2 |
93,536,133 |
93,540,734 |
RGD:6480464 |
CTD |
| G |
Fadd |
Fas (TNFRSF6)-associated via death domain |
|
decreases expression |
ISO |
1 |
205,010,363 |
205,012,768 |
RGD:6480464 |
CTD |
| G |
Faim3 |
Fas apoptotic inhibitory molecule 3 |
|
affects expression |
ISO |
13 |
43,815,827 |
43,830,062 |
RGD:6480464 |
CTD |
| G |
Fam45a |
family with sequence similarity 45, member A |
|
increases expression |
ISO |
1 |
267,417,683 |
267,441,183 |
RGD:6480464 |
CTD |
| G |
Fas |
Fas (TNF receptor superfamily, member 6) |
|
decreases expression |
ISO |
1 |
238,259,443 |
238,274,745 |
RGD:6480464 |
CTD |
| G |
Fasn |
fatty acid synthase |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Fbxo21 |
F-box protein 21 |
|
decreases expression |
ISO |
12 |
39,719,654 |
39,753,892 |
RGD:6480464 |
CTD |
| G |
Fbxo31 |
F-box protein 31 |
|
decreases expression |
ISO |
19 |
51,836,918 |
51,837,223 |
RGD:6480464 |
CTD |
| G |
Fgf1 |
fibroblast growth factor 1 (acidic) |
|
decreases expression |
ISO |
18 |
31,785,480 |
31,806,452 |
RGD:6480464 |
CTD |
| G |
Fgfr1op2 |
FGFR1 oncogene partner 2 |
|
increases expression |
ISO |
4 |
184,153,022 |
184,173,961 |
RGD:6480464 |
CTD |
| G |
Fibp |
fibroblast growth factor (acidic) intracellular binding protein |
|
affects expression |
ISO |
1 |
208,104,191 |
208,108,458 |
RGD:6480464 |
CTD |
| G |
Flcn |
folliculin |
|
decreases expression |
ISO |
10 |
46,110,527 |
46,129,613 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
multiple interactions |
ISO |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
increases expression |
ISO |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
increases expression |
ISO |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
multiple interactions |
ISO |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
increases expression |
ISO |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Foxc1 |
forkhead box C1 |
|
increases expression |
ISO |
17 |
39,026,186 |
39,030,163 |
RGD:6480464 |
CTD |
| G |
Fpgs |
folylpolyglutamate synthase |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Frmd8 |
FERM domain containing 8 |
|
increases expression |
ISO |
1 |
208,489,337 |
208,509,947 |
RGD:6480464 |
CTD |
| G |
Fshb |
follicle stimulating hormone, beta polypeptide |
|
multiple interactions |
ISO |
3 |
92,569,344 |
92,571,254 |
RGD:6480464 |
CTD |
| G |
Fshb |
follicle stimulating hormone, beta polypeptide |
|
increases expression |
ISO |
3 |
92,569,344 |
92,571,254 |
RGD:6480464 |
CTD |
| G |
Fubp1 |
far upstream element (FUSE) binding protein 1 |
|
decreases expression |
ISO |
2 |
250,749,095 |
250,777,521 |
RGD:6480464 |
CTD |
| G |
G6pc |
glucose-6-phosphatase, catalytic subunit |
|
increases expression |
ISO |
10 |
90,393,531 |
90,403,485 |
RGD:6480464 |
CTD |
| G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
|
decreases expression |
ISO |
4 |
96,649,941 |
96,652,243 |
RGD:6480464 |
CTD |
| G |
Gale |
UDP-galactose-4-epimerase |
|
increases expression |
ISO |
5 |
154,745,853 |
154,750,357 |
RGD:6480464 |
CTD |
| G |
Gas2l3 |
growth arrest-specific 2 like 3 |
|
increases expression |
ISO |
7 |
26,150,699 |
26,170,382 |
RGD:6480464 |
CTD |
| G |
Gata4 |
GATA binding protein 4 |
|
decreases expression |
ISO |
15 |
42,472,793 |
42,519,569 |
RGD:6480464 |
CTD |
| G |
Gca |
grancalcin |
|
increases expression |
ISO |
3 |
44,616,037 |
44,648,897 |
RGD:6480464 |
CTD |
| G |
Gck |
glucokinase |
|
increases expression |
ISO |
14 |
86,572,518 |
86,587,723 |
RGD:6480464 |
CTD |
| G |
Gfap |
glial fibrillary acidic protein |
|
increases expression |
ISO |
10 |
92,059,881 |
92,068,555 |
RGD:6480464 |
CTD |
| G |
Gfap |
glial fibrillary acidic protein |
|
increases expression |
ISO |
10 |
92,059,881 |
92,068,555 |
RGD:6480464 |
CTD |
| G |
Ghr |
growth hormone receptor |
|
increases expression |
EXP |
2 |
52,496,517 |
52,658,066 |
RGD:6480464 |
CTD |
| G |
Ghrh |
growth hormone releasing hormone |
|
increases expression |
EXP |
3 |
148,027,235 |
148,046,352 |
RGD:6480464 |
CTD |
| G |
Gimap5 |
GTPase, IMAP family member 5 |
|
increases expression |
EXP |
4 |
76,836,521 |
76,843,214 |
RGD:6480464 |
CTD |
| G |
Gins1 |
GINS complex subunit 1 (Psf1 homolog) |
|
increases expression |
ISO |
3 |
141,535,210 |
141,557,391 |
RGD:6480464 |
CTD |
| G |
Gins2 |
GINS complex subunit 2 (Psf2 homolog) |
|
increases expression |
ISO |
19 |
50,915,108 |
50,927,668 |
RGD:6480464 |
CTD |
| G |
Gja1 |
gap junction protein, alpha 1 |
|
increases expression |
ISO |
20 |
35,409,815 |
35,422,262 |
RGD:6480464 |
CTD |
| G |
Gja1 |
gap junction protein, alpha 1 |
|
decreases expression |
EXP |
20 |
35,409,815 |
35,422,262 |
RGD:6480464 |
CTD |
| G |
Gja5 |
gap junction protein, alpha 5 |
|
increases expression |
EXP |
2 |
191,824,118 |
191,843,867 |
RGD:6480464 |
CTD |
| G |
Glcci1 |
glucocorticoid induced transcript 1 |
|
affects methylation |
ISO |
4 |
33,531,086 |
33,659,344 |
RGD:6480464 |
CTD |
| G |
Glrx2 |
glutaredoxin 2 |
|
increases expression |
ISO |
13 |
57,567,017 |
57,589,873 |
RGD:6480464 |
CTD |
| G |
Glrx3 |
glutaredoxin 3 |
|
decreases expression |
ISO |
1 |
197,176,020 |
197,206,249 |
RGD:6480464 |
CTD |
| G |
Gls |
glutaminase |
|
affects expression |
ISO |
9 |
46,380,165 |
46,452,974 |
RGD:6480464 |
CTD |
| G |
Glul |
glutamate-ammonia ligase |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Gmnn |
geminin |
|
increases expression |
ISO |
17 |
47,372,316 |
47,380,559 |
RGD:6480464 |
CTD |
| G |
Gna12 |
guanine nucleotide binding protein (G protein) alpha 12 |
|
increases expression |
ISO |
12 |
14,275,708 |
14,354,843 |
RGD:6480464 |
CTD |
| G |
Gnai1 |
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1 |
|
decreases expression |
ISO |
4 |
12,465,089 |
12,495,028 |
RGD:6480464 |
CTD |
| G |
Gnas |
GNAS complex locus |
|
affects expression |
ISO |
3 |
165,213,399 |
165,214,551 |
RGD:6480464 |
CTD |
| G |
Gngt1 |
guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 1 |
|
increases expression |
ISO |
4 |
28,831,171 |
28,834,156 |
RGD:6480464 |
CTD |
| G |
Gnrh1 |
gonadotropin-releasing hormone 1 (luteinizing-releasing hormone) |
|
increases expression |
ISO |
15 |
47,303,309 |
47,307,517 |
RGD:6480464 |
CTD |
| G |
Gnrh1 |
gonadotropin-releasing hormone 1 (luteinizing-releasing hormone) |
|
affects expression |
EXP |
15 |
47,303,309 |
47,307,517 |
RGD:6480464 |
CTD |
| G |
Gnrh1 |
gonadotropin-releasing hormone 1 (luteinizing-releasing hormone) |
|
affects secretion |
EXP |
15 |
47,303,309 |
47,307,517 |
RGD:6480464 |
CTD |
| G |
Gnrh1 |
gonadotropin-releasing hormone 1 (luteinizing-releasing hormone) |
|
multiple interactions |
EXP |
15 |
47,303,309 |
47,307,517 |
RGD:6480464 |
CTD |
| G |
Gnrh1 |
gonadotropin-releasing hormone 1 (luteinizing-releasing hormone) |
|
affects secretion |
EXP |
15 |
47,303,309 |
47,307,517 |
RGD:6480464 |
CTD |
| G |
Got1 |
glutamic-oxaloacetic transaminase 1, soluble (aspartate aminotransferase 1) |
|
increases expression |
ISO |
1 |
247,324,285 |
247,347,553 |
RGD:6480464 |
CTD |
| G |
Got1 |
glutamic-oxaloacetic transaminase 1, soluble (aspartate aminotransferase 1) |
|
increases expression |
EXP |
1 |
247,324,285 |
247,347,553 |
RGD:6480464 |
CTD |
| G |
Gp2 |
glycoprotein 2 (zymogen granule membrane) |
|
increases expression |
EXP |
1 |
177,709,931 |
177,725,490 |
RGD:6480464 |
CTD |
| G |
Gpam |
glycerol-3-phosphate acyltransferase, mitochondrial |
|
increases expression |
ISO |
1 |
261,370,264 |
261,431,434 |
RGD:6480464 |
CTD |
| G |
Gpat2 |
glycerol-3-phosphate acyltransferase 2, mitochondrial |
|
increases expression |
ISO |
3 |
114,930,678 |
114,939,231 |
RGD:6480464 |
CTD |
| G |
Gper |
G protein-coupled estrogen receptor 1 |
|
multiple interactions |
ISO |
12 |
15,718,615 |
15,719,893 |
RGD:6480464 |
CTD |
| G |
Gper |
G protein-coupled estrogen receptor 1 |
|
multiple interactions |
ISO |
12 |
15,718,615 |
15,719,893 |
RGD:6480464 |
CTD |
| G |
Gper |
G protein-coupled estrogen receptor 1 |
|
multiple interactions |
ISO |
12 |
15,718,615 |
15,719,893 |
RGD:6480464 |
CTD |
| G |
Gpm6b |
glycoprotein m6b |
|
increases expression |
EXP |
X |
48,746,584 |
48,788,414 |
RGD:6480464 |
CTD |
| G |
Gpr161 |
G protein-coupled receptor 161 |
|
decreases expression |
ISO |
13 |
81,053,624 |
81,074,896 |
RGD:6480464 |
CTD |
| G |
Gprc5a |
G protein-coupled receptor, family C, group 5, member A |
|
decreases expression |
ISO |
4 |
171,987,364 |
172,006,276 |
RGD:6480464 |
CTD |
| G |
Gprc5a |
G protein-coupled receptor, family C, group 5, member A |
|
affects expression |
ISO |
4 |
171,987,364 |
172,006,276 |
RGD:6480464 |
CTD |
| G |
Gprin2 |
G protein regulated inducer of neurite outgrowth 2 |
|
decreases expression |
ISO |
16 |
9,824,551 |
9,825,918 |
RGD:6480464 |
CTD |
| G |
Grb14 |
growth factor receptor bound protein 14 |
|
affects expression |
ISO |
3 |
46,832,380 |
46,952,670 |
RGD:6480464 |
CTD |
| G |
Grin1 |
glutamate receptor, ionotropic, N-methyl D-aspartate 1 |
|
increases phosphorylation |
EXP |
3 |
3,453,784 |
3,480,381 |
RGD:6480464 |
CTD |
| G |
Grin1 |
glutamate receptor, ionotropic, N-methyl D-aspartate 1 |
|
multiple interactions |
EXP |
3 |
3,453,784 |
3,480,381 |
RGD:6480464 |
CTD |
| G |
Grin1 |
glutamate receptor, ionotropic, N-methyl D-aspartate 1 |
|
increases expression |
EXP |
3 |
3,453,784 |
3,480,381 |
RGD:6480464 |
CTD |
| G |
Grin2b |
glutamate receptor, ionotropic, N-methyl D-aspartate 2B |
|
multiple interactions |
EXP |
4 |
172,721,895 |
173,183,187 |
RGD:6480464 |
CTD |
| G |
Grin2b |
glutamate receptor, ionotropic, N-methyl D-aspartate 2B |
|
increases phosphorylation |
EXP |
4 |
172,721,895 |
173,183,187 |
RGD:6480464 |
CTD |
| G |
Grin2b |
glutamate receptor, ionotropic, N-methyl D-aspartate 2B |
|
multiple interactions |
EXP |
4 |
172,721,895 |
173,183,187 |
RGD:6480464 |
CTD |
| G |
Grin2b |
glutamate receptor, ionotropic, N-methyl D-aspartate 2B |
|
multiple interactions |
EXP |
4 |
172,721,895 |
173,183,187 |
RGD:6480464 |
CTD |
| G |
Grin2b |
glutamate receptor, ionotropic, N-methyl D-aspartate 2B |
|
multiple interactions |
EXP |
4 |
172,721,895 |
173,183,187 |
RGD:6480464 |
CTD |
| G |
Grin2b |
glutamate receptor, ionotropic, N-methyl D-aspartate 2B |
|
increases phosphorylation |
EXP |
4 |
172,721,895 |
173,183,187 |
RGD:6480464 |
CTD |
| G |
Hand2 |
heart and neural crest derivatives expressed 2 |
|
decreases expression |
ISO |
16 |
36,324,327 |
36,348,104 |
RGD:6480464 |
CTD |
| G |
Hectd1 |
HECT domain containing E3 ubiquitin protein ligase 1 |
|
decreases expression |
ISO |
6 |
71,842,842 |
71,930,042 |
RGD:6480464 |
CTD |
| G |
Hes6 |
hairy and enhancer of split 6 (Drosophila) |
|
increases expression |
ISO |
9 |
90,639,890 |
90,641,596 |
RGD:6480464 |
CTD |
| G |
Hist1h1b |
histone cluster 1, H1b |
|
increases expression |
ISO |
17 |
50,360,616 |
50,361,284 |
RGD:6480464 |
CTD |
| G |
Hmgcr |
3-hydroxy-3-methylglutaryl-CoA reductase |
|
increases expression |
ISO |
2 |
27,127,504 |
27,149,580 |
RGD:6480464 |
CTD |
| G |
Hmox2 |
heme oxygenase (decycling) 2 |
|
affects expression |
ISO |
10 |
10,914,157 |
10,929,448 |
RGD:6480464 |
CTD |
| G |
Hoxa11 |
homeobox A11 |
|
increases expression |
ISO |
4 |
80,542,417 |
80,546,079 |
RGD:6480464 |
CTD |
| G |
Hoxa11 |
homeobox A11 |
|
decreases methylation |
ISO |
4 |
80,542,417 |
80,546,079 |
RGD:6480464 |
CTD |
| G |
Hoxa11 |
homeobox A11 |
|
decreases expression |
EXP |
4 |
80,542,417 |
80,546,079 |
RGD:6480464 |
CTD |
| G |
Hoxa11 |
homeobox A11 |
|
decreases expression |
EXP |
4 |
80,542,417 |
80,546,079 |
RGD:6480464 |
CTD |
| G |
Hoxc5 |
homeo box C5 |
|
increases expression |
ISO |
7 |
141,777,331 |
141,780,753 |
RGD:6480464 |
CTD |
| G |
Hpcal1 |
hippocalcin-like 1 |
|
multiple interactions |
EXP |
6 |
41,458,062 |
41,576,771 |
RGD:6480464 |
CTD |
| G |
Hps5 |
Hermansky-Pudlak syndrome 5 |
|
decreases expression |
ISO |
1 |
97,312,474 |
97,351,792 |
RGD:6480464 |
CTD |
| G |
Hras |
Harvey rat sarcoma virus oncogene |
|
affects expression |
ISO |
1 |
201,385,705 |
201,388,987 |
RGD:6480464 |
CTD |
| G |
Hsd17b1 |
hydroxysteroid (17-beta) dehydrogenase 1 |
|
multiple interactions |
ISO |
10 |
90,094,249 |
90,096,451 |
RGD:6480464 |
CTD |
| G |
Hsd17b1 |
hydroxysteroid (17-beta) dehydrogenase 1 |
|
decreases expression |
ISO |
10 |
90,094,249 |
90,096,451 |
RGD:6480464 |
CTD |
| G |
Hsd17b2 |
hydroxysteroid (17-beta) dehydrogenase 2 |
|
multiple interactions |
ISO |
19 |
47,729,519 |
47,802,933 |
RGD:6480464 |
CTD |
| G |
Hsd17b2 |
hydroxysteroid (17-beta) dehydrogenase 2 |
|
decreases expression |
EXP |
19 |
47,729,519 |
47,802,933 |
RGD:6480464 |
CTD |
| G |
Hsd17b3 |
hydroxysteroid (17-beta) dehydrogenase 3 |
|
decreases expression |
EXP |
17 |
6,554,164 |
6,585,525 |
RGD:6480464 |
CTD |
| G |
Hsd17b6 |
hydroxysteroid (17-beta) dehydrogenase 6 |
|
decreases expression |
ISO |
7 |
1,118,183 |
1,137,670 |
RGD:6480464 |
CTD |
| G |
Hspa5 |
heat shock protein 5 |
|
increases expression |
ISO |
3 |
13,783,825 |
13,788,022 |
RGD:6480464 |
CTD |
| G |
Hspa5 |
heat shock protein 5 |
|
increases expression |
ISO |
3 |
13,783,825 |
13,788,022 |
RGD:6480464 |
CTD |
| G |
Htra2 |
HtrA serine peptidase 2 |
|
affects expression |
ISO |
4 |
117,262,206 |
117,265,368 |
RGD:6480464 |
CTD |
| G |
Hus1 |
HUS1 checkpoint homolog (S. pombe) |
|
increases expression |
ISO |
14 |
89,527,997 |
89,542,730 |
RGD:6480464 |
CTD |
| G |
Ifih1 |
interferon induced with helicase C domain 1 |
|
increases expression |
ISO |
3 |
44,547,092 |
44,593,969 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
affects expression |
ISO |
7 |
24,531,669 |
24,605,742 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
multiple interactions |
ISO |
7 |
24,531,669 |
24,605,742 |
RGD:6480464 |
CTD |
| G |
Igf2r |
insulin-like growth factor 2 receptor |
|
multiple interactions |
ISO |
1 |
42,253,273 |
42,341,646 |
RGD:6480464 |
CTD |
| G |
Igf2r |
insulin-like growth factor 2 receptor |
|
decreases methylation |
ISO |
1 |
42,253,273 |
42,341,646 |
RGD:6480464 |
CTD |
| G |
Igfbp1 |
insulin-like growth factor binding protein 1 |
|
increases expression |
ISO |
14 |
87,950,222 |
87,955,289 |
RGD:6480464 |
CTD |
| G |
Igfbp4 |
insulin-like growth factor binding protein 4 |
|
increases expression |
ISO |
10 |
87,822,429 |
87,834,315 |
RGD:6480464 |
CTD |
| G |
Igfbp5 |
insulin-like growth factor binding protein 5 |
|
affects expression |
ISO |
9 |
72,003,637 |
72,016,263 |
RGD:6480464 |
CTD |
| G |
Il13ra1 |
interleukin 13 receptor, alpha 1 |
|
decreases expression |
ISO |
X |
8,758,662 |
8,820,545 |
RGD:6480464 |
CTD |
| G |
Il13ra1 |
interleukin 13 receptor, alpha 1 |
|
increases methylation |
ISO |
X |
8,758,662 |
8,820,545 |
RGD:6480464 |
CTD |
| G |
Il15ra |
interleukin 15 receptor, alpha |
|
decreases expression |
ISO |
17 |
77,998,621 |
78,029,657 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
increases expression |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il4 |
interleukin 4 |
|
multiple interactions |
ISO |
10 |
39,074,582 |
39,080,134 |
RGD:6480464 |
CTD |
| G |
Il4r |
interleukin 4 receptor |
|
increases expression |
EXP |
1 |
184,612,903 |
184,637,863 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases expression |
EXP |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
EXP |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Ilf2 |
interleukin enhancer binding factor 2 |
|
increases expression |
ISO |
2 |
182,741,739 |
182,761,593 |
RGD:6480464 |
CTD |
| G |
Impdh2 |
IMP (inosine 5'-monophosphate) dehydrogenase 2 |
|
increases expression |
ISO |
8 |
113,607,025 |
113,611,613 |
RGD:6480464 |
CTD |
| G |
Inhbb |
inhibin beta-B |
|
increases expression |
ISO |
13 |
32,170,987 |
32,176,689 |
RGD:6480464 |
CTD |
| G |
Inhbe |
inhibin beta E |
|
affects expression |
ISO |
7 |
67,308,713 |
67,310,138 |
RGD:6480464 |
CTD |
| G |
Ins1 |
insulin 1 |
|
multiple interactions |
ISO |
1 |
258,001,134 |
258,001,688 |
RGD:6480464 |
CTD |
| G |
Ins1 |
insulin 1 |
|
affects secretion |
ISO |
1 |
258,001,134 |
258,001,688 |
RGD:6480464 |
CTD |
| G |
Ins1 |
insulin 1 |
|
increases expression |
ISO |
1 |
258,001,134 |
258,001,688 |
RGD:6480464 |
CTD |
| G |
Ins1 |
insulin 1 |
|
increases expression |
ISO |
1 |
258,001,134 |
258,001,688 |
RGD:6480464 |
CTD |
| G |
Ins1 |
insulin 1 |
|
increases secretion |
ISO |
1 |
258,001,134 |
258,001,688 |
RGD:6480464 |
CTD |
| G |
Ins1 |
insulin 1 |
|
multiple interactions |
ISO |
1 |
258,001,134 |
258,001,688 |
RGD:6480464 |
CTD |
| G |
Ins1 |
insulin 1 |
|
decreases expression |
EXP |
1 |
258,001,134 |
258,001,688 |
RGD:6480464 |
CTD |
| G |
Ins1 |
insulin 1 |
|
increases expression |
EXP |
1 |
258,001,134 |
258,001,688 |
RGD:6480464 |
CTD |
| G |
Ins1 |
insulin 1 |
|
multiple interactions |
ISO |
1 |
258,001,134 |
258,001,688 |
RGD:6480464 |
CTD |
| G |
Ins1 |
insulin 1 |
|
multiple interactions |
EXP |
1 |
258,001,134 |
258,001,688 |
RGD:6480464 |
CTD |
| G |
Ins1 |
insulin 1 |
|
increases secretion |
EXP |
1 |
258,001,134 |
258,001,688 |
RGD:6480464 |
CTD |
| G |
Ins2 |
insulin 2 |
|
multiple interactions |
ISO |
1 |
202,935,548 |
202,936,379 |
RGD:6480464 |
CTD |
| G |
Ins2 |
insulin 2 |
|
increases secretion |
ISO |
1 |
202,935,548 |
202,936,379 |
RGD:6480464 |
CTD |
| G |
Ins2 |
insulin 2 |
|
increases expression |
ISO |
1 |
202,935,548 |
202,936,379 |
RGD:6480464 |
CTD |
| G |
Ins2 |
insulin 2 |
|
multiple interactions |
ISO |
1 |
202,935,548 |
202,936,379 |
RGD:6480464 |
CTD |
| G |
Insc |
inscuteable homolog (Drosophila) |
|
increases expression |
ISO |
1 |
172,804,412 |
172,913,667 |
RGD:6480464 |
CTD |
| G |
Insig1 |
insulin induced gene 1 |
|
increases expression |
ISO |
4 |
2,577,468 |
2,585,682 |
RGD:6480464 |
CTD |
| G |
Insig1 |
insulin induced gene 1 |
|
affects expression |
ISO |
4 |
2,577,468 |
2,585,682 |
RGD:6480464 |
CTD |
| G |
Insig1 |
insulin induced gene 1 |
|
affects expression |
ISO |
4 |
2,577,468 |
2,585,682 |
RGD:6480464 |
CTD |
| G |
Insig1 |
insulin induced gene 1 |
|
increases expression |
EXP |
4 |
2,577,468 |
2,585,682 |
RGD:6480464 |
CTD |
| G |
Insig1 |
insulin induced gene 1 |
|
affects expression |
ISO |
4 |
2,577,468 |
2,585,682 |
RGD:6480464 |
CTD |
| G |
Insr |
insulin receptor |
|
decreases expression |
EXP |
12 |
2,934,967 |
3,087,691 |
RGD:6480464 |
CTD |
| G |
Ipo13 |
importin 13 |
|
increases expression |
ISO |
5 |
138,359,940 |
138,380,170 |
RGD:6480464 |
CTD |
| G |
Ipo13 |
importin 13 |
|
increases expression |
ISO |
5 |
138,359,940 |
138,380,170 |
RGD:6480464 |
CTD |
| G |
Ipo4 |
importin 4 |
|
increases expression |
ISO |
15 |
33,761,275 |
33,771,195 |
RGD:6480464 |
CTD |
| G |
Iqcb1 |
IQ motif containing B1 |
|
decreases expression |
ISO |
11 |
65,708,818 |
65,763,303 |
RGD:6480464 |
CTD |
| G |
Iqch |
IQ motif containing H |
|
affects expression |
ISO |
8 |
67,583,147 |
67,777,098 |
RGD:6480464 |
CTD |
| G |
Irak1 |
interleukin-1 receptor-associated kinase 1 |
|
affects expression |
ISO |
X |
159,960,184 |
159,969,180 |
RGD:6480464 |
CTD |
| G |
Irs1 |
insulin receptor substrate 1 |
|
decreases expression |
EXP |
9 |
81,585,251 |
81,638,071 |
RGD:6480464 |
CTD |
| G |
Irs1 |
insulin receptor substrate 1 |
|
increases expression |
ISO |
9 |
81,585,251 |
81,638,071 |
RGD:6480464 |
CTD |
| G |
Irs2 |
insulin receptor substrate 2 |
|
decreases expression |
EXP |
16 |
83,379,987 |
83,404,220 |
RGD:6480464 |
CTD |
| G |
Itgb2 |
integrin, beta 2 |
|
increases expression |
ISO |
20 |
11,446,521 |
11,485,009 |
RGD:6480464 |
CTD |
| G |
Itgb3 |
integrin, beta 3 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Itgb3 |
integrin, beta 3 |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Itgb8 |
integrin, beta 8 |
|
decreases expression |
ISO |
6 |
146,494,978 |
146,573,064 |
RGD:6480464 |
CTD |
| G |
Itpk1 |
inositol-tetrakisphosphate 1-kinase |
|
increases expression |
ISO |
6 |
126,837,135 |
126,969,350 |
RGD:6480464 |
CTD |
| G |
Itpr1 |
inositol 1,4,5-trisphosphate receptor, type 1 |
|
increases expression |
ISO |
4 |
143,705,360 |
144,030,051 |
RGD:6480464 |
CTD |
| G |
Ivd |
isovaleryl-CoA dehydrogenase |
|
decreases expression |
ISO |
3 |
105,374,429 |
105,394,861 |
RGD:6480464 |
CTD |
| G |
Jrk |
jerky homolog (mouse) |
|
increases expression |
ISO |
7 |
112,819,393 |
112,824,076 |
RGD:6480464 |
CTD |
| G |
Jrk |
jerky homolog (mouse) |
|
multiple interactions |
ISO |
7 |
112,819,393 |
112,824,076 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
increases expression |
ISO |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
multiple interactions |
ISO |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Junb |
jun B proto-oncogene |
|
decreases expression |
ISO |
19 |
24,831,536 |
24,833,320 |
RGD:6480464 |
CTD |
| G |
Jup |
junction plakoglobin |
|
decreases expression |
ISO |
10 |
89,307,938 |
89,335,254 |
RGD:6480464 |
CTD |
| G |
Katna1 |
katanin p60 (ATPase-containing) subunit A1 |
|
decreases expression |
ISO |
1 |
2,394,947 |
2,436,574 |
RGD:6480464 |
CTD |
| G |
Kctd9 |
potassium channel tetramerisation domain containing 9 |
|
increases expression |
ISO |
15 |
47,272,273 |
47,300,689 |
RGD:6480464 |
CTD |
| G |
Kdr |
kinase insert domain receptor |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Kiss1 |
KiSS-1 metastasis-suppressor |
|
increases expression |
ISO |
13 |
46,244,786 |
46,247,288 |
RGD:6480464 |
CTD |
| G |
Kiss1 |
KiSS-1 metastasis-suppressor |
|
decreases expression |
EXP |
13 |
46,244,786 |
46,247,288 |
RGD:6480464 |
CTD |
| G |
Kiss1 |
KiSS-1 metastasis-suppressor |
|
decreases expression |
EXP |
13 |
46,244,786 |
46,247,288 |
RGD:6480464 |
CTD |
| G |
Klhl41 |
kelch-like family member 41 |
|
increases expression |
EXP |
3 |
51,816,016 |
51,829,140 |
RGD:6480464 |
CTD |
| G |
Lalba |
lactalbumin, alpha |
|
decreases expression |
EXP |
7 |
137,220,916 |
137,223,614 |
RGD:6480464 |
CTD |
| G |
Lemd3 |
LEM domain containing 3 |
|
increases expression |
ISO |
7 |
60,232,118 |
60,281,459 |
RGD:6480464 |
CTD |
| G |
Lep |
leptin |
|
increases expression |
ISO |
4 |
55,943,837 |
55,945,938 |
RGD:6480464 |
CTD |
| G |
Lep |
leptin |
|
increases expression |
ISO |
4 |
55,943,837 |
55,945,938 |
RGD:6480464 |
CTD |
| G |
Lepr |
leptin receptor |
|
increases expression |
ISO |
5 |
122,320,075 |
122,503,449 |
RGD:6480464 |
CTD |
| G |
Lhb |
luteinizing hormone beta |
|
multiple interactions |
EXP |
1 |
95,892,999 |
95,893,988 |
RGD:6480464 |
CTD |
| G |
Lhb |
luteinizing hormone beta |
|
multiple interactions |
EXP |
1 |
95,892,999 |
95,893,988 |
RGD:6480464 |
CTD |
| G |
Lhb |
luteinizing hormone beta |
|
increases expression |
EXP |
1 |
95,892,999 |
95,893,988 |
RGD:6480464 |
CTD |
| G |
Lhb |
luteinizing hormone beta |
|
multiple interactions |
EXP |
1 |
95,892,999 |
95,893,988 |
RGD:6480464 |
CTD |
| G |
Lhb |
luteinizing hormone beta |
|
decreases expression |
EXP |
1 |
95,892,999 |
95,893,988 |
RGD:6480464 |
CTD |
| G |
Lhb |
luteinizing hormone beta |
|
decreases expression |
EXP |
1 |
95,892,999 |
95,893,988 |
RGD:6480464 |
CTD |
| G |
Lhb |
luteinizing hormone beta |
|
affects expression |
ISO |
1 |
95,892,999 |
95,893,988 |
RGD:6480464 |
CTD |
| G |
Lhcgr |
luteinizing hormone/choriogonadotropin receptor |
|
decreases expression |
EXP |
6 |
12,613,622 |
12,651,587 |
RGD:6480464 |
CTD |
| G |
Lims1 |
LIM and senescent cell antigen-like domains 1 |
|
increases expression |
ISO |
20 |
37,349,188 |
37,397,427 |
RGD:6480464 |
CTD |
| G |
LOC100359600 |
karyopherin alpha 2-like |
|
increases expression |
ISO |
6 |
10,523,393 |
10,524,982 |
RGD:6480464 |
CTD |
| G |
LOC100361349 |
hypothetical protein LOC100361349 |
|
increases expression |
ISO |
2 |
185,155,651 |
185,161,067 |
RGD:6480464 |
CTD |
| G |
Lpar1 |
lysophosphatidic acid receptor 1 |
|
increases expression |
EXP |
5 |
76,449,470 |
76,571,458 |
RGD:6480464 |
CTD |
| G |
Lpin1 |
lipin 1 |
|
increases expression |
ISO |
6 |
40,253,664 |
40,297,195 |
RGD:6480464 |
CTD |
| G |
Lpl |
lipoprotein lipase |
|
multiple interactions |
ISO |
16 |
22,533,105 |
22,556,905 |
RGD:6480464 |
CTD |
| G |
Lrrc28 |
leucine rich repeat containing 28 |
|
increases expression |
ISO |
1 |
122,267,092 |
122,385,096 |
RGD:6480464 |
CTD |
| G |
Lss |
lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) |
|
increases expression |
ISO |
20 |
12,507,575 |
12,534,612 |
RGD:6480464 |
CTD |
| G |
Mageb4 |
melanoma antigen family B, 4 |
|
increases expression |
ISO |
X |
79,295,352 |
79,364,435 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases phosphorylation |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases phosphorylation |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
affects activity |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases phosphorylation |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases phosphorylation |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases phosphorylation |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases phosphorylation |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
increases phosphorylation |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
affects activity |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
increases phosphorylation |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
increases phosphorylation |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
increases phosphorylation |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
increases phosphorylation |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
increases phosphorylation |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mat2a |
methionine adenosyltransferase II, alpha |
|
decreases expression |
ISO |
4 |
105,739,943 |
105,745,472 |
RGD:6480464 |
CTD |
| G |
Maz |
MYC-associated zinc finger protein (purine-binding transcription factor) |
|
affects expression |
ISO |
1 |
186,201,083 |
186,204,364 |
RGD:6480464 |
CTD |
| G |
Mblac2 |
metallo-beta-lactamase domain containing 2 |
|
increases expression |
ISO |
2 |
9,804,235 |
9,847,031 |
RGD:6480464 |
CTD |
| G |
Mbnl2 |
muscleblind-like splicing regulator 2 |
|
increases expression |
ISO |
15 |
105,356,456 |
105,514,135 |
RGD:6480464 |
CTD |
| G |
Mcl1 |
myeloid cell leukemia sequence 1 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Mcm6 |
minichromosome maintenance complex component 6 |
|
increases expression |
ISO |
13 |
41,045,677 |
41,070,868 |
RGD:6480464 |
CTD |
| G |
Mcm7 |
minichromosome maintenance complex component 7 |
|
increases expression |
ISO |
12 |
17,607,250 |
17,614,508 |
RGD:6480464 |
CTD |
| G |
Mcpt1 |
mast cell protease 1 |
|
increases expression |
EXP |
15 |
34,270,481 |
34,273,035 |
RGD:6480464 |
CTD |
| G |
Me1 |
malic enzyme 1, NADP(+)-dependent, cytosolic |
|
affects expression |
ISO |
8 |
91,839,845 |
91,955,917 |
RGD:6480464 |
CTD |
| G |
Med1 |
mediator complex subunit 1 |
|
multiple interactions |
ISO |
10 |
86,917,525 |
86,959,080 |
RGD:6480464 |
CTD |
| G |
Med6 |
mediator complex subunit 6 |
|
affects expression |
ISO |
6 |
105,432,911 |
105,446,531 |
RGD:6480464 |
CTD |
| G |
Med8 |
mediator complex subunit 8 |
|
affects expression |
ISO |
5 |
138,895,040 |
138,895,924 |
RGD:6480464 |
CTD |
| G |
Mef2c |
myocyte enhancer factor 2C |
|
increases expression |
ISO |
2 |
12,331,078 |
12,346,520 |
RGD:6480464 |
CTD |
| G |
Melk |
maternal embryonic leucine zipper kinase |
|
increases expression |
ISO |
5 |
60,787,123 |
60,848,620 |
RGD:6480464 |
CTD |
| G |
Meox1 |
mesenchyme homeobox 1 |
|
decreases expression |
ISO |
10 |
90,921,589 |
90,942,298 |
RGD:6480464 |
CTD |
| G |
Meox1 |
mesenchyme homeobox 1 |
|
affects expression |
ISO |
10 |
90,921,589 |
90,942,298 |
RGD:6480464 |
CTD |
| G |
Mettl21d |
methyltransferase like 21D |
|
decreases expression |
ISO |
6 |
91,602,980 |
91,610,509 |
RGD:6480464 |
CTD |
| G |
Mfge8 |
milk fat globule-EGF factor 8 protein |
|
decreases expression |
ISO |
1 |
134,870,029 |
134,885,431 |
RGD:6480464 |
CTD |
| G |
Mfsd10 |
major facilitator superfamily domain containing 10 |
|
affects expression |
ISO |
14 |
81,745,997 |
81,748,824 |
RGD:6480464 |
CTD |
| G |
Mga |
MGA, MAX dimerization protein |
|
decreases expression |
ISO |
3 |
106,407,792 |
106,474,833 |
RGD:6480464 |
CTD |
| G |
Mgst1 |
microsomal glutathione S-transferase 1 |
|
decreases expression |
EXP |
4 |
175,248,654 |
175,263,881 |
RGD:6480464 |
CTD |
| G |
Mia |
melanoma inhibitory activity |
|
increases expression |
EXP |
1 |
82,255,458 |
82,257,125 |
RGD:6480464 |
CTD |
| G |
Mkln1 |
muskelin 1, intracellular mediator containing kelch motifs |
|
decreases expression |
ISO |
4 |
58,475,702 |
58,600,770 |
RGD:6480464 |
CTD |
| G |
Mlf1 |
myeloid leukemia factor 1 |
|
increases expression |
ISO |
2 |
157,230,783 |
157,263,847 |
RGD:6480464 |
CTD |
| G |
Mlf1ip |
MLF1 interacting protein |
|
increases expression |
ISO |
16 |
48,997,465 |
49,020,684 |
RGD:6480464 |
CTD |
| G |
Mlh1 |
mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli) |
|
increases expression |
ISO |
8 |
115,616,396 |
115,653,471 |
RGD:6480464 |
CTD |
| G |
Mlph |
melanophilin |
|
increases expression |
ISO |
9 |
90,113,308 |
90,149,114 |
RGD:6480464 |
CTD |
| G |
Mlph |
melanophilin |
|
affects expression |
ISO |
9 |
90,113,308 |
90,149,114 |
RGD:6480464 |
CTD |
| G |
Mlxipl |
MLX interacting protein-like |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Mmadhc |
methylmalonic aciduria (cobalamin deficiency) cblD type, with homocystinuria |
|
decreases expression |
EXP |
3 |
31,224,132 |
31,242,473 |
RGD:6480464 |
CTD |
| G |
Mme |
membrane metallo-endopeptidase |
|
decreases expression |
ISO |
2 |
153,031,724 |
153,114,515 |
RGD:6480464 |
CTD |
| G |
Mmp1 |
matrix metallopeptidase 1 (interstitial collagenase) |
|
multiple interactions |
ISO |
8 |
4,333,773 |
4,354,284 |
RGD:6480464 |
CTD |
| G |
Mmp10 |
matrix metallopeptidase 10 (stromelysin 2) |
|
affects expression |
ISO |
8 |
4,367,842 |
4,375,737 |
RGD:6480464 |
CTD |
| G |
Mocs1 |
molybdenum cofactor synthesis 1 |
|
increases expression |
ISO |
9 |
6,759,531 |
6,779,930 |
RGD:6480464 |
CTD |
| G |
Mocs2 |
molybdenum cofactor synthesis 2 |
|
increases expression |
ISO |
2 |
46,948,321 |
46,960,060 |
RGD:6480464 |
CTD |
| G |
Mospd1 |
motile sperm domain containing 1 |
|
decreases expression |
ISO |
X |
140,301,920 |
140,329,537 |
RGD:6480464 |
CTD |
| G |
Mospd3 |
motile sperm domain containing 3 |
|
decreases expression |
ISO |
12 |
19,663,139 |
19,666,904 |
RGD:6480464 |
CTD |
| G |
Mphosph9 |
M-phase phosphoprotein 9 |
|
increases expression |
ISO |
12 |
33,394,159 |
33,457,830 |
RGD:6480464 |
CTD |
| G |
Mpp2 |
membrane protein, palmitoylated 2 (MAGUK p55 subfamily member 2) |
|
increases expression |
ISO |
10 |
91,125,953 |
91,156,804 |
RGD:6480464 |
CTD |
| G |
Mpzl1 |
myelin protein zero-like 1 |
|
decreases expression |
ISO |
13 |
81,321,155 |
81,357,929 |
RGD:6480464 |
CTD |
| G |
Mreg |
melanoregulin |
|
decreases expression |
ISO |
9 |
71,303,627 |
71,357,985 |
RGD:6480464 |
CTD |
| G |
Mrps14 |
mitochondrial ribosomal protein S14 |
|
increases expression |
ISO |
13 |
75,614,841 |
75,620,588 |
RGD:6480464 |
CTD |
| G |
Mrps15 |
mitochondrial ribosomal protein S15 |
|
decreases expression |
ISO |
5 |
145,397,772 |
145,408,365 |
RGD:6480464 |
CTD |
| G |
Ms4a6c |
membrane-spanning 4-domains, subfamily A, member 6C |
|
decreases expression |
ISO |
1 |
214,302,173 |
214,310,702 |
RGD:6480464 |
CTD |
| G |
Ms4a6c |
membrane-spanning 4-domains, subfamily A, member 6C |
|
multiple interactions |
ISO |
1 |
214,302,173 |
214,310,702 |
RGD:6480464 |
CTD |
| G |
Msh4 |
mutS homolog 4 (E. coli) |
|
increases expression |
ISO |
2 |
251,801,090 |
251,851,133 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
multiple interactions |
ISO |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mtif2 |
mitochondrial translational initiation factor 2 |
|
decreases expression |
ISO |
14 |
110,538,911 |
110,559,208 |
RGD:6480464 |
CTD |
| G |
Mtl5 |
metallothionein-like 5, testis-specific (tesmin) |
|
increases expression |
ISO |
1 |
205,916,071 |
205,934,347 |
RGD:6480464 |
CTD |
| G |
Mvd |
mevalonate (diphospho) decarboxylase |
|
increases expression |
ISO |
19 |
52,722,306 |
52,732,312 |
RGD:6480464 |
CTD |
| G |
Mybbp1a |
MYB binding protein (P160) 1a |
|
increases expression |
ISO |
10 |
59,325,648 |
59,335,604 |
RGD:6480464 |
CTD |
| G |
Myc |
myelocytomatosis oncogene |
|
affects expression |
ISO |
7 |
98,953,142 |
98,958,060 |
RGD:6480464 |
CTD |
| G |
Mycbp |
c-myc binding protein |
|
decreases expression |
ISO |
5 |
143,196,136 |
143,203,083 |
RGD:6480464 |
CTD |
| G |
Myo10 |
myosin X |
|
increases expression |
ISO |
2 |
77,183,028 |
77,385,896 |
RGD:6480464 |
CTD |
| G |
Myo1e |
myosin IE |
|
increases expression |
ISO |
8 |
74,680,727 |
74,884,376 |
RGD:6480464 |
CTD |
| G |
Nabp1 |
nucleic acid binding protein 1 |
|
increases expression |
ISO |
9 |
47,194,891 |
47,201,876 |
RGD:6480464 |
CTD |
| G |
Nans |
N-acetylneuraminic acid synthase |
|
increases expression |
ISO |
5 |
63,072,673 |
63,090,183 |
RGD:6480464 |
CTD |
| G |
Ncoa1 |
nuclear receptor coactivator 1 |
|
multiple interactions |
ISO |
6 |
27,224,396 |
27,473,926 |
RGD:6480464 |
CTD |
| G |
Ncoa1 |
nuclear receptor coactivator 1 |
|
multiple interactions |
ISO |
6 |
27,224,396 |
27,473,926 |
RGD:6480464 |
CTD |
| G |
Ncoa1 |
nuclear receptor coactivator 1 |
|
increases expression |
EXP |
6 |
27,224,396 |
27,473,926 |
RGD:6480464 |
CTD |
| G |
Ncoa2 |
nuclear receptor coactivator 2 |
|
increases expression |
EXP |
5 |
5,197,891 |
5,275,776 |
RGD:6480464 |
CTD |
| G |
Ncoa3 |
nuclear receptor coactivator 3 |
|
decreases expression |
EXP |
3 |
157,168,492 |
157,196,566 |
RGD:6480464 |
CTD |
| G |
Ncoa3 |
nuclear receptor coactivator 3 |
|
increases expression |
EXP |
3 |
157,168,492 |
157,196,566 |
RGD:6480464 |
CTD |
| G |
Ncor1 |
nuclear receptor co-repressor 1 |
|
multiple interactions |
ISO |
10 |
48,481,110 |
48,628,538 |
RGD:6480464 |
CTD |
| G |
Ncor1 |
nuclear receptor co-repressor 1 |
|
multiple interactions |
ISO |
10 |
48,481,110 |
48,628,538 |
RGD:6480464 |
CTD |
| G |
Ncor2 |
nuclear receptor co-repressor 2 |
|
multiple interactions |
ISO |
12 |
32,617,643 |
32,725,753 |
RGD:6480464 |
CTD |
| G |
Ncor2 |
nuclear receptor co-repressor 2 |
|
multiple interactions |
ISO |
12 |
32,617,643 |
32,725,753 |
RGD:6480464 |
CTD |
| G |
Ncor2 |
nuclear receptor co-repressor 2 |
|
affects expression |
EXP |
12 |
32,617,643 |
32,725,753 |
RGD:6480464 |
CTD |
| G |
Nfe2 |
nuclear factor, erythroid derived 2 |
|
increases expression |
ISO |
7 |
142,157,045 |
142,164,122 |
RGD:6480464 |
CTD |
| G |
Nlrp12 |
NLR family, pyrin domain containing 12 |
|
decreases expression |
ISO |
1 |
64,242,875 |
64,271,212 |
RGD:6480464 |
CTD |
| G |
Nol3 |
nucleolar protein 3 (apoptosis repressor with CARD domain) |
|
affects expression |
ISO |
19 |
35,094,345 |
35,096,012 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
increases phosphorylation |
ISO |
4 |
6,158,847 |
6,179,441 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
increases expression |
ISO |
4 |
6,158,847 |
6,179,441 |
RGD:6480464 |
CTD |
| G |
Notch1 |
notch 1 |
|
decreases expression |
ISO |
3 |
4,631,797 |
4,677,640 |
RGD:6480464 |
CTD |
| G |
Npc1 |
Niemann-Pick disease, type C1 |
|
decreases expression |
ISO |
18 |
3,725,415 |
3,777,707 |
RGD:6480464 |
CTD |
| G |
Nr1h3 |
nuclear receptor subfamily 1, group H, member 3 |
|
increases expression |
ISO |
3 |
75,542,211 |
75,550,793 |
RGD:6480464 |
CTD |
| G |
Nr1h3 |
nuclear receptor subfamily 1, group H, member 3 |
|
increases expression |
ISO |
3 |
75,542,211 |
75,550,793 |
RGD:6480464 |
CTD |
| G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
|
multiple interactions |
ISO |
11 |
64,239,918 |
64,276,702 |
RGD:6480464 |
CTD |
| G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
|
increases activity |
ISO |
11 |
64,239,918 |
64,276,702 |
RGD:6480464 |
CTD |
| G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
|
increases activity |
ISO |
11 |
64,239,918 |
64,276,702 |
RGD:6480464 |
CTD |
| G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
|
multiple interactions |
ISO |
11 |
64,239,918 |
64,276,702 |
RGD:6480464 |
CTD |
| G |
Nr1i3 |
nuclear receptor subfamily 1, group I, member 3 |
|
multiple interactions |
ISO |
13 |
87,104,241 |
87,108,563 |
RGD:6480464 |
CTD |
| G |
Nr1i3 |
nuclear receptor subfamily 1, group I, member 3 |
|
decreases expression |
ISO |
13 |
87,104,241 |
87,108,563 |
RGD:6480464 |
CTD |
| G |
Nr4a1 |
nuclear receptor subfamily 4, group A, member 1 |
|
increases expression |
ISO |
7 |
140,012,807 |
140,020,590 |
RGD:6480464 |
CTD |
| G |
Nr5a1 |
nuclear receptor subfamily 5, group A, member 1 |
|
decreases expression |
ISO |
3 |
18,498,913 |
18,519,738 |
RGD:6480464 |
CTD |
| G |
Nr5a1 |
nuclear receptor subfamily 5, group A, member 1 |
|
increases expression |
ISO |
3 |
18,498,913 |
18,519,738 |
RGD:6480464 |
CTD |
| G |
Nsdhl |
NAD(P) dependent steroid dehydrogenase-like |
|
increases expression |
ISO |
X |
158,923,025 |
158,954,914 |
RGD:6480464 |
CTD |
| G |
Nxpe2 |
neurexophilin and PC-esterase domain family, member 2 |
|
decreases expression |
ISO |
8 |
51,611,643 |
51,623,632 |
RGD:6480464 |
CTD |
| G |
Olfml3 |
olfactomedin-like 3 |
|
increases expression |
ISO |
2 |
198,958,480 |
198,961,309 |
RGD:6480464 |
CTD |
| G |
Os9 |
osteosarcoma amplified 9 |
|
increases expression |
ISO |
7 |
67,046,802 |
67,073,355 |
RGD:6480464 |
CTD |
| G |
Osbpl8 |
oxysterol binding protein-like 8 |
|
increases expression |
ISO |
7 |
50,308,713 |
50,313,369 |
RGD:6480464 |
CTD |
| G |
Ostc |
oligosaccharyltransferase complex subunit (non-catalytic) |
|
increases expression |
ISO |
2 |
228,112,093 |
228,127,992 |
RGD:6480464 |
CTD |
| G |
Oxtr |
oxytocin receptor |
|
decreases expression |
ISO |
4 |
148,314,089 |
148,326,797 |
RGD:6480464 |
CTD |
| G |
Pabpn1 |
poly(A) binding protein, nuclear 1 |
|
decreases expression |
ISO |
15 |
32,994,493 |
32,999,104 |
RGD:6480464 |
CTD |
| G |
Paqr7 |
progestin and adipoQ receptor family member VII |
|
decreases expression |
ISO |
5 |
153,263,432 |
153,264,469 |
RGD:6480464 |
CTD |
| G |
Patz1 |
POZ (BTB) and AT hook containing zinc finger 1 |
|
increases expression |
ISO |
14 |
83,905,714 |
83,936,768 |
RGD:6480464 |
CTD |
| G |
Pbld1 |
phenazine biosynthesis-like protein domain containing 1 |
|
affects expression |
ISO |
20 |
25,413,994 |
25,428,299 |
RGD:6480464 |
CTD |
| G |
Pbld2 |
phenazine biosynthesis-like protein domain containing 2 |
|
affects expression |
ISO |
20 |
25,379,865 |
25,410,260 |
RGD:6480464 |
CTD |
| G |
Pbsn |
probasin |
|
affects expression |
ISO |
X |
63,581,742 |
63,597,497 |
RGD:6480464 |
CTD |
| G |
Pbx1 |
pre-B-cell leukemia homeobox 1 |
|
increases expression |
ISO |
13 |
83,839,256 |
84,115,516 |
RGD:6480464 |
CTD |
| G |
Pcaf |
p300/CBP-associated factor |
|
affects expression |
ISO |
9 |
882,928 |
889,661 |
RGD:6480464 |
CTD |
| G |
Pcbp2 |
poly(rC) binding protein 2 |
|
increases expression |
ISO |
7 |
141,232,766 |
141,253,910 |
RGD:6480464 |
CTD |
| G |
Pcbp4 |
poly(rC) binding protein 4 |
|
decreases expression |
ISO |
8 |
111,597,539 |
111,607,775 |
RGD:6480464 |
CTD |
| G |
Pck1 |
phosphoenolpyruvate carboxykinase 1 (soluble) |
|
increases expression |
ISO |
3 |
164,012,410 |
164,018,359 |
RGD:6480464 |
CTD |
| G |
Pcna |
proliferating cell nuclear antigen |
|
increases expression |
ISO |
3 |
120,008,715 |
120,012,589 |
RGD:6480464 |
CTD |
| G |
Pcna |
proliferating cell nuclear antigen |
|
increases expression |
ISO |
3 |
120,008,715 |
120,012,589 |
RGD:6480464 |
CTD |
| G |
Pcna |
proliferating cell nuclear antigen |
|
increases expression |
ISO |
3 |
120,008,715 |
120,012,589 |
RGD:6480464 |
CTD |
| G |
Pcna |
proliferating cell nuclear antigen |
|
increases expression |
ISO |
3 |
120,008,715 |
120,012,589 |
RGD:6480464 |
CTD |
| G |
Pcna |
proliferating cell nuclear antigen |
|
increases expression |
ISO |
3 |
120,008,715 |
120,012,589 |
RGD:6480464 |
CTD |
| G |
Pcp4 |
Purkinje cell protein 4 |
|
increases expression |
ISO |
11 |
36,828,273 |
36,889,381 |
RGD:6480464 |
CTD |
| G |
Pcp4l1 |
Purkinje cell protein 4-like 1 |
|
decreases expression |
ISO |
13 |
87,059,476 |
87,083,085 |
RGD:6480464 |
CTD |
| G |
Pcyt1a |
phosphate cytidylyltransferase 1, choline, alpha |
|
increases expression |
ISO |
11 |
70,133,325 |
70,173,686 |
RGD:6480464 |
CTD |
| G |
Pdcd7 |
programmed cell death 7 |
|
increases expression |
ISO |
8 |
69,590,408 |
69,605,671 |
RGD:6480464 |
CTD |
| G |
Pde4b |
phosphodiesterase 4B, cAMP specific |
|
increases expression |
ISO |
5 |
123,158,156 |
123,533,877 |
RGD:6480464 |
CTD |
| G |
Pde4c |
phosphodiesterase 4C, cAMP-specific |
|
decreases expression |
ISO |
16 |
19,197,277 |
19,215,627 |
RGD:6480464 |
CTD |
| G |
Pde4d |
phosphodiesterase 4D, cAMP-specific |
|
decreases methylation |
EXP |
2 |
40,196,097 |
41,311,012 |
RGD:6480464 |
CTD |
| G |
Pde4d |
phosphodiesterase 4D, cAMP-specific |
|
increases expression |
EXP |
2 |
40,196,097 |
41,311,012 |
RGD:6480464 |
CTD |
| G |
Pde4dip |
phosphodiesterase 4D interacting protein |
|
increases expression |
ISO |
2 |
192,534,747 |
192,671,053 |
RGD:6480464 |
CTD |
| G |
Pde4dip |
phosphodiesterase 4D interacting protein |
|
increases expression |
EXP |
2 |
192,534,747 |
192,671,053 |
RGD:6480464 |
CTD |
| G |
Pdgfa |
platelet-derived growth factor alpha polypeptide |
|
increases expression |
ISO |
12 |
16,151,045 |
16,172,412 |
RGD:6480464 |
CTD |
| G |
Pdgfra |
platelet derived growth factor receptor, alpha polypeptide |
|
increases expression |
EXP |
14 |
35,369,422 |
35,418,126 |
RGD:6480464 |
CTD |
| G |
Pdgfrb |
platelet derived growth factor receptor, beta polypeptide |
|
increases expression |
EXP |
18 |
57,014,475 |
57,053,581 |
RGD:6480464 |
CTD |
| G |
Pdhb |
pyruvate dehydrogenase (lipoamide) beta |
|
increases expression |
ISO |
15 |
18,737,449 |
18,743,391 |
RGD:6480464 |
CTD |
| G |
Pdk1 |
pyruvate dehydrogenase kinase, isozyme 1 |
|
increases expression |
EXP |
3 |
54,292,076 |
54,319,242 |
RGD:6480464 |
CTD |
| G |
Pdk4 |
pyruvate dehydrogenase kinase, isozyme 4 |
|
affects expression |
ISO |
4 |
30,235,296 |
30,245,298 |
RGD:6480464 |
CTD |
| G |
Peg3 |
paternally expressed 3 |
|
decreases methylation |
ISO |
1 |
65,513,912 |
65,526,040 |
RGD:6480464 |
CTD |
| G |
Peli1 |
pellino E3 ubiquitin protein ligase 1 |
|
decreases expression |
ISO |
14 |
101,870,272 |
101,924,228 |
RGD:6480464 |
CTD |
| G |
Penk |
proenkephalin |
|
increases expression |
ISO |
5 |
17,509,323 |
17,514,265 |
RGD:6480464 |
CTD |
| G |
Per1 |
period circadian clock 1 |
|
increases expression |
ISO |
10 |
55,859,851 |
55,868,747 |
RGD:6480464 |
CTD |
| G |
Per2 |
period circadian clock 2 |
|
increases expression |
ISO |
9 |
90,645,342 |
90,687,509 |
RGD:6480464 |
CTD |
| G |
Pex13 |
peroxisomal biogenesis factor 13 |
|
decreases expression |
ISO |
14 |
104,550,699 |
104,571,485 |
RGD:6480464 |
CTD |
| G |
Pex2 |
peroxisomal biogenesis factor 2 |
|
increases expression |
ISO |
2 |
98,361,891 |
98,378,715 |
RGD:6480464 |
CTD |
| G |
Pex2 |
peroxisomal biogenesis factor 2 |
|
multiple interactions |
ISO |
2 |
98,361,891 |
98,378,715 |
RGD:6480464 |
CTD |
| G |
Pfkfb4 |
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 |
|
increases expression |
EXP |
8 |
114,012,543 |
114,050,534 |
RGD:6480464 |
CTD |
| G |
Pfkm |
phosphofructokinase, muscle |
|
increases expression |
EXP |
7 |
136,826,122 |
136,846,040 |
RGD:6480464 |
CTD |
| G |
Pfkp |
phosphofructokinase, platelet |
|
increases expression |
EXP |
17 |
74,760,912 |
74,823,046 |
RGD:6480464 |
CTD |
| G |
Pgam2 |
phosphoglycerate mutase 2 (muscle) |
|
increases expression |
EXP |
14 |
86,466,055 |
86,468,166 |
RGD:6480464 |
CTD |
| G |
Pgk1 |
phosphoglycerate kinase 1 |
|
increases expression |
EXP |
X |
94,324,219 |
94,340,193 |
RGD:6480464 |
CTD |
| G |
Pgr |
progesterone receptor |
|
multiple interactions |
ISO |
8 |
5,784,717 |
5,845,901 |
RGD:6480464 |
CTD |
| G |
Pgr |
progesterone receptor |
|
affects expression |
ISO |
8 |
5,784,717 |
5,845,901 |
RGD:6480464 |
CTD |
| G |
Pgr |
progesterone receptor |
|
decreases expression |
EXP |
8 |
5,784,717 |
5,845,901 |
RGD:6480464 |
CTD |
| G |
Pgr |
progesterone receptor |
|
decreases expression |
EXP |
8 |
5,784,717 |
5,845,901 |
RGD:6480464 |
CTD |
| G |
Pgr |
progesterone receptor |
|
increases expression |
EXP |
8 |
5,784,717 |
5,845,901 |
RGD:6480464 |
CTD |
| G |
Pgr |
progesterone receptor |
|
increases expression |
EXP |
8 |
5,784,717 |
5,845,901 |
RGD:6480464 |
CTD |
| G |
Pgr |
progesterone receptor |
|
increases expression |
ISO |
8 |
5,784,717 |
5,845,901 |
RGD:6480464 |
CTD |
| G |
Pgr |
progesterone receptor |
|
decreases expression |
EXP |
8 |
5,784,717 |
5,845,901 |
RGD:6480464 |
CTD |
| G |
Pgr |
progesterone receptor |
|
increases expression |
EXP |
8 |
5,784,717 |
5,845,901 |
RGD:6480464 |
CTD |
| G |
Pgr |
progesterone receptor |
|
increases expression |
ISO |
8 |
5,784,717 |
5,845,901 |
RGD:6480464 |
CTD |
| G |
Pgr |
progesterone receptor |
|
increases expression |
ISO |
8 |
5,784,717 |
5,845,901 |
RGD:6480464 |
CTD |
| G |
Pgr |
progesterone receptor |
|
affects binding |
ISO |
8 |
5,784,717 |
5,845,901 |
RGD:6480464 |
CTD |
| G |
Pgr |
progesterone receptor |
|
multiple interactions |
ISO |
8 |
5,784,717 |
5,845,901 |
RGD:6480464 |
CTD |
| G |
Pgr |
progesterone receptor |
|
increases expression |
ISO |
8 |
5,784,717 |
5,845,901 |
RGD:6480464 |
CTD |
| G |
Pgr |
progesterone receptor |
|
multiple interactions |
ISO |
8 |
5,784,717 |
5,845,901 |
RGD:6480464 |
CTD |
| G |
Pgr |
progesterone receptor |
|
increases expression |
ISO |
8 |
5,784,717 |
5,845,901 |
RGD:6480464 |
CTD |
| G |
Phf11 |
PHD finger protein 11 |
|
decreases expression |
ISO |
15 |
38,443,971 |
38,477,944 |
RGD:6480464 |
CTD |
| G |
Pi4k2a |
phosphatidylinositol 4-kinase type 2 alpha |
|
increases expression |
ISO |
1 |
248,736,384 |
248,760,679 |
RGD:6480464 |
CTD |
| G |
Pik3r1 |
phosphoinositide-3-kinase, regulatory subunit 1 (alpha) |
|
increases expression |
ISO |
2 |
32,602,673 |
32,675,350 |
RGD:6480464 |
CTD |
| G |
Pik3r1 |
phosphoinositide-3-kinase, regulatory subunit 1 (alpha) |
|
decreases expression |
EXP |
2 |
32,602,673 |
32,675,350 |
RGD:6480464 |
CTD |
| G |
Pim1 |
pim-1 oncogene |
|
affects expression |
ISO |
20 |
7,817,403 |
7,821,800 |
RGD:6480464 |
CTD |
| G |
Pip5k1a |
phosphatidylinositol-4-phosphate 5-kinase, type 1, alpha |
|
increases expression |
ISO |
2 |
189,962,527 |
190,005,684 |
RGD:6480464 |
CTD |
| G |
Pip5k1a |
phosphatidylinositol-4-phosphate 5-kinase, type 1, alpha |
|
multiple interactions |
ISO |
2 |
189,962,527 |
190,005,684 |
RGD:6480464 |
CTD |
| G |
Pkhd1 |
polycystic kidney and hepatic disease 1 |
|
increases expression |
ISO |
9 |
18,833,903 |
19,338,716 |
RGD:6480464 |
CTD |
| G |
Plxna4a |
plexin A4, A |
|
affects expression |
ISO |
4 |
59,254,319 |
59,692,187 |
RGD:6480464 |
CTD |
| G |
Pnpla3 |
patatin-like phospholipase domain containing 3 |
|
increases expression |
ISO |
7 |
122,152,092 |
122,171,994 |
RGD:6480464 |
CTD |
| G |
Pnpla5 |
patatin-like phospholipase domain containing 5 |
|
increases expression |
ISO |
7 |
122,105,019 |
122,116,003 |
RGD:6480464 |
CTD |
| G |
Polr3g |
polymerase (RNA) III (DNA directed) polypeptide G |
|
increases expression |
ISO |
2 |
9,763,378 |
9,804,285 |
RGD:6480464 |
CTD |
| G |
Pop1 |
processing of precursor 1, ribonuclease P/MRP subunit (S. cerevisiae) |
|
decreases expression |
ISO |
7 |
69,944,414 |
69,979,794 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
decreases expression |
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppard |
peroxisome proliferator-activated receptor delta |
|
increases expression |
ISO |
20 |
6,479,108 |
6,544,255 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
increases expression |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
increases localization |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
multiple interactions |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
increases expression |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
increases expression |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Ppfibp2 |
PTPRF interacting protein, binding protein 2 (liprin beta 2) |
|
decreases expression |
ISO |
1 |
164,979,709 |
165,125,077 |
RGD:6480464 |
CTD |
| G |
Prl |
prolactin |
|
multiple interactions |
ISO |
17 |
44,699,101 |
44,709,162 |
RGD:6480464 |
CTD |
| G |
Prl |
prolactin |
|
increases secretion |
EXP |
17 |
44,699,101 |
44,709,162 |
RGD:6480464 |
CTD |
| G |
Prl |
prolactin |
|
increases secretion |
EXP |
17 |
44,699,101 |
44,709,162 |
RGD:6480464 |
CTD |
| G |
Prlr |
prolactin receptor |
|
decreases expression |
EXP |
2 |
59,507,966 |
59,701,221 |
RGD:6480464 |
CTD |
| G |
Ptafr |
platelet-activating factor receptor |
|
affects expression |
ISO |
5 |
152,565,687 |
152,587,342 |
RGD:6480464 |
CTD |
| G |
Pten |
phosphatase and tensin homolog |
|
increases phosphorylation |
ISO |
1 |
236,771,027 |
236,837,261 |
RGD:6480464 |
CTD |
| G |
Pten |
phosphatase and tensin homolog |
|
decreases expression |
ISO |
1 |
236,771,027 |
236,837,261 |
RGD:6480464 |
CTD |
| G |
Rab11fip4 |
RAB11 family interacting protein 4 (class II) |
|
decreases expression |
ISO |
10 |
65,780,123 |
65,883,833 |
RGD:6480464 |
CTD |
| G |
Rab23 |
RAB23, member RAS oncogene family |
|
increases expression |
ISO |
9 |
32,465,752 |
32,486,615 |
RGD:6480464 |
CTD |
| G |
Rab30 |
RAB30, member RAS oncogene family |
|
decreases expression |
ISO |
1 |
149,656,373 |
149,670,208 |
RGD:6480464 |
CTD |
| G |
Rab31 |
RAB31, member RAS oncogene family |
|
increases expression |
ISO |
9 |
104,408,546 |
104,543,084 |
RGD:6480464 |
CTD |
| G |
Rab32 |
RAB32, member RAS oncogene family |
|
affects expression |
ISO |
1 |
5,203,908 |
5,218,416 |
RGD:6480464 |
CTD |
| G |
Rad1 |
RAD1 homolog (S. pombe) |
|
decreases expression |
ISO |
2 |
59,837,934 |
59,845,973 |
RGD:6480464 |
CTD |
| G |
Ralgps1 |
Ral GEF with PH domain and SH3 binding motif 1 |
|
increases expression |
ISO |
3 |
12,146,421 |
12,379,365 |
RGD:6480464 |
CTD |
| G |
Ran |
RAN, member RAS oncogene family |
|
affects expression |
ISO |
12 |
28,736,786 |
28,739,921 |
RGD:6480464 |
CTD |
| G |
Rara |
retinoic acid receptor, alpha |
|
increases expression |
ISO |
10 |
87,740,479 |
87,753,265 |
RGD:6480464 |
CTD |
| G |
Rb1 |
retinoblastoma 1 |
|
multiple interactions |
ISO |
15 |
53,828,881 |
53,962,099 |
RGD:6480464 |
CTD |
| G |
Rb1 |
retinoblastoma 1 |
|
increases phosphorylation |
ISO |
15 |
53,828,881 |
53,962,099 |
RGD:6480464 |
CTD |
| G |
Rbm24 |
RNA binding motif protein 24 |
|
affects expression |
ISO |
17 |
24,217,930 |
24,229,736 |
RGD:6480464 |
CTD |
| G |
Rbm38 |
RNA binding motif protein 38 |
|
decreases expression |
ISO |
3 |
163,885,488 |
163,898,314 |
RGD:6480464 |
CTD |
| G |
Rbms2 |
RNA binding motif, single stranded interacting protein 2 |
|
affects expression |
ISO |
7 |
1,426,634 |
1,462,518 |
RGD:6480464 |
CTD |
| G |
Rbp4 |
retinol binding protein 4, plasma |
|
decreases expression |
EXP |
1 |
242,443,795 |
242,450,997 |
RGD:6480464 |
CTD |
| G |
Rcan1 |
regulator of calcineurin 1 |
|
increases expression |
ISO |
11 |
32,386,576 |
32,408,850 |
RGD:6480464 |
CTD |
| G |
Rdh11 |
retinol dehydrogenase 11 (all-trans/9-cis/11-cis) |
|
increases expression |
ISO |
6 |
101,946,431 |
101,962,606 |
RGD:6480464 |
CTD |
| G |
Rec8 |
REC8 homolog (yeast) |
|
decreases expression |
ISO |
15 |
33,753,772 |
33,761,237 |
RGD:6480464 |
CTD |
| G |
Reck |
reversion-inducing-cysteine-rich protein with kazal motifs |
|
increases expression |
ISO |
5 |
60,341,438 |
60,407,710 |
RGD:6480464 |
CTD |
| G |
Reep5 |
receptor accessory protein 5 |
|
increases expression |
ISO |
18 |
26,813,889 |
26,845,178 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Ret |
ret proto-oncogene |
|
decreases expression |
EXP |
4 |
154,448,179 |
154,491,103 |
RGD:6480464 |
CTD |
| G |
Rhob |
ras homolog family member B |
|
increases expression |
ISO |
6 |
32,052,333 |
32,054,507 |
RGD:6480464 |
CTD |
| G |
Rhobtb2 |
Rho-related BTB domain containing 2 |
|
increases expression |
ISO |
15 |
50,166,160 |
50,184,221 |
RGD:6480464 |
CTD |
| G |
Ribc2 |
RIB43A domain with coiled-coils 2 |
|
affects expression |
ISO |
7 |
123,140,197 |
123,155,197 |
RGD:6480464 |
CTD |
| G |
Ripk2 |
receptor-interacting serine-threonine kinase 2 |
|
decreases expression |
ISO |
5 |
30,714,817 |
30,745,941 |
RGD:6480464 |
CTD |
| G |
Ripk3 |
receptor-interacting serine-threonine kinase 3 |
|
increases expression |
EXP |
15 |
33,947,406 |
33,956,351 |
RGD:6480464 |
CTD |
| G |
Rmi2 |
RMI2, RecQ mediated genome instability 2, homolog (S. cerevisiae) |
|
decreases expression |
ISO |
10 |
4,765,965 |
4,771,062 |
RGD:6480464 |
CTD |
| G |
Rnaseh1 |
ribonuclease H1 |
|
increases expression |
ISO |
6 |
46,528,591 |
46,537,960 |
RGD:6480464 |
CTD |
| G |
Rnasel |
ribonuclease L (2',5'-oligoisoadenylate synthetase-dependent) |
|
increases expression |
ISO |
13 |
68,822,013 |
68,829,264 |
RGD:6480464 |
CTD |
| G |
Rnd3 |
Rho family GTPase 3 |
|
decreases expression |
ISO |
3 |
32,101,433 |
32,118,785 |
RGD:6480464 |
CTD |
| G |
Rnf38 |
ring finger protein 38 |
|
increases expression |
EXP |
5 |
60,600,918 |
60,631,312 |
RGD:6480464 |
CTD |
| G |
Rngtt |
RNA guanylyltransferase and 5'-phosphatase |
|
decreases expression |
ISO |
5 |
49,605,150 |
49,811,502 |
RGD:6480464 |
CTD |
| G |
Rnls |
renalase, FAD-dependent amine oxidase |
|
decreases expression |
ISO |
1 |
237,364,578 |
237,639,800 |
RGD:6480464 |
CTD |
| G |
Rnls |
renalase, FAD-dependent amine oxidase |
|
increases expression |
ISO |
1 |
237,364,578 |
237,639,800 |
RGD:6480464 |
CTD |
| G |
Ror2 |
receptor tyrosine kinase-like orphan receptor 2 |
|
decreases expression |
ISO |
17 |
17,735,999 |
17,917,032 |
RGD:6480464 |
CTD |
| G |
Rorc |
RAR-related orphan receptor C |
|
decreases expression |
ISO |
2 |
189,345,134 |
189,369,442 |
RGD:6480464 |
CTD |
| G |
Rpa1 |
replication protein A1 |
|
increases expression |
ISO |
10 |
62,613,169 |
62,656,565 |
RGD:6480464 |
CTD |
| G |
Rph3a |
rabphilin 3A |
|
increases expression |
EXP |
12 |
36,678,613 |
36,753,316 |
RGD:6480464 |
CTD |
| G |
Rpia |
ribose 5-phosphate isomerase A |
|
increases expression |
ISO |
4 |
103,934,938 |
103,960,574 |
RGD:6480464 |
CTD |
| G |
Rpn2 |
ribophorin II |
|
increases expression |
EXP |
3 |
147,976,544 |
148,023,743 |
RGD:6480464 |
CTD |
| G |
Rps27l |
ribosomal protein S27-like |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Rps27l2 |
ribosomal protein S27-like 2 |
|
increases expression |
ISO |
12 |
29,143,461 |
29,143,842 |
RGD:6480464 |
CTD |
| G |
Rps6 |
ribosomal protein S6 |
|
decreases expression |
ISO |
5 |
106,165,612 |
106,168,472 |
RGD:6480464 |
CTD |
| G |
Rps6 |
ribosomal protein S6 |
|
increases phosphorylation |
ISO |
5 |
106,165,612 |
106,168,472 |
RGD:6480464 |
CTD |
| G |
Rps6 |
ribosomal protein S6 |
|
increases expression |
ISO |
5 |
106,165,612 |
106,168,472 |
RGD:6480464 |
CTD |
| G |
Rps6kb2 |
ribosomal protein S6 kinase, polypeptide 2 |
|
increases expression |
EXP |
1 |
206,740,966 |
206,747,653 |
RGD:6480464 |
CTD |
| G |
Rrm2 |
ribonucleotide reductase M2 |
|
increases expression |
ISO |
6 |
42,350,541 |
42,356,748 |
RGD:6480464 |
CTD |
| G |
RT1-Da |
RT1 class II, locus Da |
|
increases expression |
EXP |
20 |
4,636,310 |
4,641,282 |
RGD:6480464 |
CTD |
| G |
Rtl1 |
retrotransposon-like 1 |
|
affects expression |
ISO |
6 |
134,182,036 |
134,187,063 |
RGD:6480464 |
CTD |
| G |
Runx1t1 |
runt-related transcription factor 1; translocated to, 1 (cyclin D-related) |
|
increases expression |
ISO |
5 |
28,230,322 |
28,338,441 |
RGD:6480464 |
CTD |
| G |
Rxra |
retinoid X receptor alpha |
|
increases expression |
ISO |
3 |
6,605,782 |
6,689,224 |
RGD:6480464 |
CTD |
| G |
Rxra |
retinoid X receptor alpha |
|
decreases expression |
ISO |
3 |
6,605,782 |
6,689,224 |
RGD:6480464 |
CTD |
| G |
Rxra |
retinoid X receptor alpha |
|
increases expression |
ISO |
3 |
6,605,782 |
6,689,224 |
RGD:6480464 |
CTD |
| G |
Rxrb |
retinoid X receptor beta |
|
increases activity |
ISO |
20 |
4,954,336 |
4,960,880 |
RGD:6480464 |
CTD |
| G |
S100a1 |
S100 calcium binding protein A1 |
|
affects expression |
ISO |
2 |
182,784,818 |
182,787,370 |
RGD:6480464 |
CTD |
| G |
S100g |
S100 calcium binding protein G |
|
increases expression |
EXP |
X |
52,446,817 |
52,449,342 |
RGD:6480464 |
CTD |
| G |
S100g |
S100 calcium binding protein G |
|
increases expression |
EXP |
X |
52,446,817 |
52,449,342 |
RGD:6480464 |
CTD |
| G |
S100g |
S100 calcium binding protein G |
|
increases expression |
EXP |
X |
52,446,817 |
52,449,342 |
RGD:6480464 |
CTD |
| G |
S100g |
S100 calcium binding protein G |
|
increases expression |
EXP |
X |
52,446,817 |
52,449,342 |
RGD:6480464 |
CTD |
| G |
S100g |
S100 calcium binding protein G |
|
increases expression |
ISO |
X |
52,446,817 |
52,449,342 |
RGD:6480464 |
CTD |
| G |
S100g |
S100 calcium binding protein G |
|
multiple interactions |
ISO |
X |
52,446,817 |
52,449,342 |
RGD:6480464 |
CTD |
| G |
Sac3d1 |
SAC3 domain containing 1 |
|
increases expression |
ISO |
1 |
208,889,495 |
208,891,944 |
RGD:6480464 |
CTD |
| G |
Sc5d |
sterol-C5-desaturase |
|
increases expression |
ISO |
8 |
45,229,976 |
45,238,924 |
RGD:6480464 |
CTD |
| G |
Scd1 |
stearoyl-Coenzyme A desaturase 1 |
|
increases expression |
ISO |
1 |
249,458,860 |
249,471,460 |
RGD:6480464 |
CTD |
| G |
Sclt1 |
sodium channel and clathrin linker 1 |
|
decreases expression |
ISO |
2 |
128,562,358 |
128,732,751 |
RGD:6480464 |
CTD |
| G |
Sec16a |
SEC16 homolog A (S. cerevisiae) |
|
multiple interactions |
ISO |
3 |
4,583,882 |
4,613,980 |
RGD:6480464 |
CTD |
| G |
Sec16a |
SEC16 homolog A (S. cerevisiae) |
|
decreases expression |
ISO |
3 |
4,583,882 |
4,613,980 |
RGD:6480464 |
CTD |
| G |
Slc12a9 |
solute carrier family 12 (potassium/chloride transporters), member 9 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Slc1a1 |
solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1 |
|
increases expression |
ISO |
1 |
232,469,746 |
232,549,584 |
RGD:6480464 |
CTD |
| G |
Slc22a18 |
solute carrier family 22, member 18 |
|
affects expression |
ISO |
1 |
203,852,313 |
203,876,165 |
RGD:6480464 |
CTD |
| G |
Slc22a5 |
solute carrier family 22 (organic cation/carnitine transporter), member 5 |
|
decreases expression |
ISO |
10 |
39,311,729 |
39,338,718 |
RGD:6480464 |
CTD |
| G |
Slc25a44 |
solute carrier family 25, member 44 |
|
increases expression |
ISO |
2 |
180,512,111 |
180,526,810 |
RGD:6480464 |
CTD |
| G |
Slc27a1 |
solute carrier family 27 (fatty acid transporter), member 1 |
|
increases expression |
ISO |
16 |
18,769,909 |
18,786,988 |
RGD:6480464 |
CTD |
| G |
Slc27a2 |
solute carrier family 27 (fatty acid transporter), member 2 |
|
decreases expression |
ISO |
3 |
114,072,570 |
114,114,269 |
RGD:6480464 |
CTD |
| G |
Slc27a5 |
solute carrier family 27 (fatty acid transporter), member 5 |
|
increases expression |
ISO |
1 |
72,924,630 |
72,935,223 |
RGD:6480464 |
CTD |
| G |
Slc2a2 |
solute carrier family 2 (facilitated glucose transporter), member 2 |
|
increases expression |
ISO |
2 |
116,036,501 |
116,065,834 |
RGD:6480464 |
CTD |
| G |
Slc2a2 |
solute carrier family 2 (facilitated glucose transporter), member 2 |
|
decreases expression |
EXP |
2 |
116,036,501 |
116,065,834 |
RGD:6480464 |
CTD |
| G |
Slc2a8 |
solute carrier family 2, (facilitated glucose transporter) member 8 |
|
decreases expression |
EXP |
3 |
11,962,570 |
11,972,115 |
RGD:6480464 |
CTD |
| G |
Slc40a1 |
solute carrier family 40 (iron-regulated transporter), member 1 |
|
affects expression |
ISO |
9 |
44,977,430 |
44,995,358 |
RGD:6480464 |
CTD |
| G |
Slc6a14 |
solute carrier family 6 (amino acid transporter), member 14 |
|
increases expression |
ISO |
X |
12,048,993 |
12,072,434 |
RGD:6480464 |
CTD |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
affects localization |
EXP |
1 |
30,516,568 |
30,557,540 |
RGD:6480464 |
CTD |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
multiple interactions |
EXP |
1 |
30,516,568 |
30,557,540 |
RGD:6480464 |
CTD |
| G |
Sox9 |
SRY (sex determining region Y)-box 9 |
|
decreases expression |
ISO |
10 |
102,392,187 |
102,394,256 |
RGD:6480464 |
CTD |
| G |
Spo11 |
SPO11 meiotic protein covalently bound to DSB homolog (S. cerevisiae) |
|
increases expression |
ISO |
3 |
163,842,817 |
163,854,067 |
RGD:6480464 |
CTD |
| G |
Sqle |
squalene epoxidase |
|
increases expression |
ISO |
7 |
96,096,897 |
96,111,772 |
RGD:6480464 |
CTD |
| G |
Src |
v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) |
|
multiple interactions |
ISO |
3 |
148,157,256 |
148,170,524 |
RGD:6480464 |
CTD |
| G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
|
affects expression |
ISO |
10 |
46,461,684 |
46,483,646 |
RGD:6480464 |
CTD |
| G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
|
increases expression |
ISO |
10 |
46,461,684 |
46,483,646 |
RGD:6480464 |
CTD |
| G |
Srebf2 |
sterol regulatory element binding transcription factor 2 |
|
affects expression |
ISO |
7 |
120,522,511 |
120,580,212 |
RGD:6480464 |
CTD |
| G |
Sstr3 |
somatostatin receptor 3 |
|
increases expression |
EXP |
7 |
116,495,750 |
116,502,948 |
RGD:6480464 |
CTD |
| G |
Sstr3 |
somatostatin receptor 3 |
|
multiple interactions |
EXP |
7 |
116,495,750 |
116,502,948 |
RGD:6480464 |
CTD |
| G |
St13 |
suppression of tumorigenicity 13 |
|
increases expression |
ISO |
7 |
119,694,123 |
119,728,936 |
RGD:6480464 |
CTD |
| G |
St3gal1 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 1 |
|
increases expression |
ISO |
7 |
104,467,678 |
104,474,345 |
RGD:6480464 |
CTD |
| G |
Star |
steroidogenic acute regulatory protein |
|
decreases expression |
ISO |
16 |
70,642,580 |
70,647,203 |
RGD:6480464 |
CTD |
| G |
Star |
steroidogenic acute regulatory protein |
|
decreases expression |
ISO |
16 |
70,642,580 |
70,647,203 |
RGD:6480464 |
CTD |
| G |
Star |
steroidogenic acute regulatory protein |
|
decreases expression |
EXP |
16 |
70,642,580 |
70,647,203 |
RGD:6480464 |
CTD |
| G |
Star |
steroidogenic acute regulatory protein |
|
decreases expression |
ISO |
16 |
70,642,580 |
70,647,203 |
RGD:6480464 |
CTD |
| G |
Star |
steroidogenic acute regulatory protein |
|
decreases expression |
EXP |
16 |
70,642,580 |
70,647,203 |
RGD:6480464 |
CTD |
| G |
Star |
steroidogenic acute regulatory protein |
|
decreases expression |
ISO |
16 |
70,642,580 |
70,647,203 |
RGD:6480464 |
CTD |
| G |
Star |
steroidogenic acute regulatory protein |
|
decreases expression |
EXP |
16 |
70,642,580 |
70,647,203 |
RGD:6480464 |
CTD |
| G |
Star |
steroidogenic acute regulatory protein |
|
increases expression |
ISO |
16 |
70,642,580 |
70,647,203 |
RGD:6480464 |
CTD |
| G |
Star |
steroidogenic acute regulatory protein |
|
increases expression |
EXP |
16 |
70,642,580 |
70,647,203 |
RGD:6480464 |
CTD |
| G |
Star |
steroidogenic acute regulatory protein |
|
decreases expression |
EXP |
16 |
70,642,580 |
70,647,203 |
RGD:6480464 |
CTD |
| G |
Star |
steroidogenic acute regulatory protein |
|
multiple interactions |
EXP |
16 |
70,642,580 |
70,647,203 |
RGD:6480464 |
CTD |
| G |
Stard4 |
StAR-related lipid transfer (START) domain containing 4 |
|
increases expression |
ISO |
18 |
25,638,433 |
25,653,958 |
RGD:6480464 |
CTD |
| G |
Stat3 |
signal transducer and activator of transcription 3 (acute-phase response factor) |
|
increases expression |
ISO |
10 |
89,821,078 |
89,872,970 |
RGD:6480464 |
CTD |
| G |
Stat3 |
signal transducer and activator of transcription 3 (acute-phase response factor) |
|
increases phosphorylation |
ISO |
10 |
89,821,078 |
89,872,970 |
RGD:6480464 |
CTD |
| G |
Stat3 |
signal transducer and activator of transcription 3 (acute-phase response factor) |
|
increases response to substance |
ISO |
10 |
89,821,078 |
89,872,970 |
RGD:6480464 |
CTD |
| G |
Stat3 |
signal transducer and activator of transcription 3 (acute-phase response factor) |
|
multiple interactions |
ISO |
10 |
89,821,078 |
89,872,970 |
RGD:6480464 |
CTD |
| G |
Stat3 |
signal transducer and activator of transcription 3 (acute-phase response factor) |
|
multiple interactions |
ISO |
10 |
89,821,078 |
89,872,970 |
RGD:6480464 |
CTD |
| G |
Stat3 |
signal transducer and activator of transcription 3 (acute-phase response factor) |
|
multiple interactions |
ISO |
10 |
89,821,078 |
89,872,970 |
RGD:6480464 |
CTD |
| G |
Stat3 |
signal transducer and activator of transcription 3 (acute-phase response factor) |
|
multiple interactions |
ISO |
10 |
89,821,078 |
89,872,970 |
RGD:6480464 |
CTD |
| G |
Stat3 |
signal transducer and activator of transcription 3 (acute-phase response factor) |
|
multiple interactions |
ISO |
10 |
89,821,078 |
89,872,970 |
RGD:6480464 |
CTD |
| G |
Stat5a |
signal transducer and activator of transcription 5A |
|
increases expression |
ISO |
10 |
89,795,404 |
89,819,732 |
RGD:6480464 |
CTD |
| G |
Stc1 |
stanniocalcin 1 |
|
affects expression |
ISO |
15 |
49,566,885 |
49,577,539 |
RGD:6480464 |
CTD |
| G |
Stc2 |
stanniocalcin 2 |
|
affects expression |
ISO |
10 |
16,514,603 |
16,524,369 |
RGD:6480464 |
CTD |
| G |
Stc2 |
stanniocalcin 2 |
|
increases expression |
ISO |
10 |
16,514,603 |
16,524,369 |
RGD:6480464 |
CTD |
| G |
Steap1 |
six transmembrane epithelial antigen of the prostate 1 |
|
decreases expression |
ISO |
4 |
24,962,598 |
24,973,106 |
RGD:6480464 |
CTD |
| G |
Stk17b |
serine/threonine kinase 17b |
|
increases expression |
EXP |
9 |
52,567,310 |
52,596,817 |
RGD:6480464 |
CTD |
| G |
Stmn1 |
stathmin 1 |
|
affects expression |
ISO |
5 |
153,226,420 |
153,232,084 |
RGD:6480464 |
CTD |
| G |
Stmn1 |
stathmin 1 |
|
increases expression |
ISO |
5 |
153,226,420 |
153,232,084 |
RGD:6480464 |
CTD |
| G |
Stom |
stomatin |
|
increases expression |
ISO |
3 |
14,392,978 |
14,415,288 |
RGD:6480464 |
CTD |
| G |
Ston2 |
stonin 2 |
|
affects expression |
ISO |
6 |
115,258,140 |
115,369,129 |
RGD:6480464 |
CTD |
| G |
Stra8 |
stimulated by retinoic acid 8 |
|
decreases expression |
ISO |
4 |
62,321,565 |
62,336,954 |
RGD:6480464 |
CTD |
| G |
Sts |
steroid sulfatase (microsomal), isozyme S |
|
increases expression |
EXP |
X |
63,915,803 |
63,923,834 |
RGD:6480464 |
CTD |
| G |
Stx1a |
syntaxin 1A (brain) |
|
decreases expression |
ISO |
12 |
22,737,112 |
22,765,064 |
RGD:6480464 |
CTD |
| G |
Sult1a1 |
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1 |
|
increases sulfation |
ISO |
1 |
185,829,205 |
185,832,725 |
RGD:6480464 |
CTD |
| G |
Sult1a1 |
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1 |
|
multiple interactions |
ISO |
1 |
185,829,205 |
185,832,725 |
RGD:6480464 |
CTD |
| G |
Sult1a1 |
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1 |
|
increases sulfation |
ISO |
1 |
185,829,205 |
185,832,725 |
RGD:6480464 |
CTD |
| G |
Sult1e1 |
sulfotransferase family 1E, estrogen-preferring, member 1 |
|
increases expression |
EXP |
14 |
21,948,475 |
21,965,541 |
RGD:6480464 |
CTD |
| G |
Sult1e1 |
sulfotransferase family 1E, estrogen-preferring, member 1 |
|
increases sulfation |
ISO |
14 |
21,948,475 |
21,965,541 |
RGD:6480464 |
CTD |
| G |
Supv3l1 |
suppressor of var1, 3-like 1 (S. cerevisiae) |
|
decreases expression |
ISO |
20 |
29,681,431 |
29,714,796 |
RGD:6480464 |
CTD |
| G |
Svs5 |
seminal vesicle secretory protein 5 |
|
decreases expression |
EXP |
3 |
155,265,150 |
155,266,754 |
RGD:6480464 |
CTD |
| G |
Sycp2 |
synaptonemal complex protein 2 |
|
increases expression |
ISO |
3 |
167,437,522 |
167,502,083 |
RGD:6480464 |
CTD |
| G |
Sycp3 |
synaptonemal complex protein 3 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Syn2 |
synapsin II |
|
increases expression |
ISO |
4 |
151,255,241 |
151,413,220 |
RGD:6480464 |
CTD |
| G |
Syncrip |
synaptotagmin binding, cytoplasmic RNA interacting protein |
|
increases expression |
ISO |
8 |
93,730,131 |
93,820,288 |
RGD:6480464 |
CTD |
| G |
Tac3 |
tachykinin 3 |
|
increases expression |
EXP |
7 |
67,717,068 |
67,723,674 |
RGD:6480464 |
CTD |
| G |
Taok3 |
TAO kinase 3 |
|
decreases expression |
ISO |
12 |
40,502,499 |
40,583,816 |
RGD:6480464 |
CTD |
| G |
Tf |
transferrin |
|
decreases expression |
EXP |
8 |
108,217,774 |
108,244,487 |
RGD:6480464 |
CTD |
| G |
Tf |
transferrin |
|
multiple interactions |
EXP |
8 |
108,217,774 |
108,244,487 |
RGD:6480464 |
CTD |
| G |
Tfap2c |
transcription factor AP-2 gamma |
|
affects expression |
ISO |
3 |
163,459,283 |
163,467,166 |
RGD:6480464 |
CTD |
| G |
Tff1 |
trefoil factor 1 |
|
increases expression |
ISO |
20 |
9,526,674 |
9,530,534 |
RGD:6480464 |
CTD |
| G |
Tff1 |
trefoil factor 1 |
|
multiple interactions |
ISO |
20 |
9,526,674 |
9,530,534 |
RGD:6480464 |
CTD |
| G |
Tff1 |
trefoil factor 1 |
|
increases expression |
ISO |
20 |
9,526,674 |
9,530,534 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
affects expression |
ISO |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb2 |
transforming growth factor, beta 2 |
|
decreases expression |
ISO |
13 |
102,718,703 |
102,818,768 |
RGD:6480464 |
CTD |
| G |
Tgfbrap1 |
transforming growth factor, beta receptor associated protein 1 |
|
affects expression |
ISO |
9 |
42,251,501 |
42,301,886 |
RGD:6480464 |
CTD |
| G |
Thbs1 |
thrombospondin 1 |
|
increases methylation |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Thbs1 |
thrombospondin 1 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Thrb |
thyroid hormone receptor beta |
|
multiple interactions |
ISO |
15 |
9,282,845 |
9,345,506 |
RGD:6480464 |
CTD |
| G |
Thrsp |
thyroid hormone responsive |
|
increases expression |
ISO |
1 |
154,647,339 |
154,651,663 |
RGD:6480464 |
CTD |
| G |
Tie1 |
tyrosine kinase with immunoglobulin-like and EGF-like domains 1 |
|
affects expression |
ISO |
5 |
138,945,238 |
138,964,631 |
RGD:6480464 |
CTD |
| G |
Timm8a1 |
translocase of inner mitochondrial membrane 8 homolog a1 (yeast) |
|
increases expression |
ISO |
X |
121,993,810 |
121,997,685 |
RGD:6480464 |
CTD |
| G |
Tlcd1 |
TLC domain containing 1 |
|
increases expression |
ISO |
10 |
64,454,775 |
64,456,808 |
RGD:6480464 |
CTD |
| G |
Tmem57 |
transmembrane protein 57 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Tmx2 |
thioredoxin-related transmembrane protein 2 |
|
increases expression |
ISO |
3 |
67,880,726 |
67,888,376 |
RGD:6480464 |
CTD |
| G |
Tmx2 |
thioredoxin-related transmembrane protein 2 |
|
increases expression |
ISO |
3 |
67,880,726 |
67,888,376 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
decreases expression |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnfrsf22 |
tumor necrosis factor receptor superfamily, member 22 |
|
affects expression |
ISO |
1 |
204,033,555 |
204,035,482 |
RGD:6480464 |
CTD |
| G |
Tnfsf11 |
tumor necrosis factor (ligand) superfamily, member 11 |
|
multiple interactions |
ISO |
15 |
59,397,837 |
59,428,014 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases expression |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Trim25 |
tripartite motif-containing 25 |
|
decreases expression |
ISO |
10 |
77,459,844 |
77,488,383 |
RGD:6480464 |
CTD |
| G |
Tsc1 |
tuberous sclerosis 1 |
|
decreases expression |
ISO |
3 |
7,645,313 |
7,672,944 |
RGD:6480464 |
CTD |
| G |
Tsc2 |
tuberous sclerosis 2 |
|
decreases expression |
ISO |
10 |
13,848,210 |
13,883,189 |
RGD:6480464 |
CTD |
| G |
Tspan33 |
tetraspanin 33 |
|
decreases expression |
ISO |
4 |
56,584,840 |
56,608,349 |
RGD:6480464 |
CTD |
| G |
Tsr1 |
TSR1, 20S rRNA accumulation, homolog (S. cerevisiae) |
|
decreases expression |
ISO |
10 |
62,207,449 |
62,218,861 |
RGD:6480464 |
CTD |
| G |
Ttc23 |
tetratricopeptide repeat domain 23 |
|
increases expression |
ISO |
1 |
122,395,433 |
122,469,865 |
RGD:6480464 |
CTD |
| G |
Ttll12 |
tubulin tyrosine ligase-like family, member 12 |
|
increases expression |
ISO |
7 |
121,601,492 |
121,620,937 |
RGD:6480464 |
CTD |
| G |
Tuba3a |
tubulin, alpha 3A |
|
increases expression |
ISO |
4 |
161,396,177 |
161,405,066 |
RGD:6480464 |
CTD |
| G |
Ugt1a1 |
UDP glucuronosyltransferase 1 family, polypeptide A1 |
|
increases expression |
ISO |
9 |
87,091,241 |
87,098,362 |
RGD:6480464 |
CTD |
| G |
Ugt1a1 |
UDP glucuronosyltransferase 1 family, polypeptide A1 |
|
increases expression |
ISO |
9 |
87,091,241 |
87,098,362 |
RGD:6480464 |
CTD |
| G |
Vcam1 |
vascular cell adhesion molecule 1 |
|
increases expression |
EXP |
2 |
212,277,654 |
212,297,376 |
RGD:6480464 |
CTD |
| G |
Vcp |
valosin-containing protein |
|
increases expression |
ISO |
5 |
59,472,100 |
59,491,508 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
increases expression |
ISO |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
increases expression |
EXP |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
multiple interactions |
ISO |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
increases secretion |
ISO |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
decreases expression |
ISO |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
decreases expression |
EXP |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
increases expression |
EXP |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Vgll1 |
vestigial like 1 (Drosophila) |
|
affects expression |
ISO |
X |
141,742,717 |
141,760,452 |
RGD:6480464 |
CTD |
| G |
Vipr2 |
vasoactive intestinal peptide receptor 2 |
|
increases expression |
ISO |
6 |
143,347,748 |
143,416,680 |
RGD:6480464 |
CTD |
| G |
Vldlr |
very low density lipoprotein receptor |
|
increases expression |
EXP |
1 |
230,666,736 |
230,697,748 |
RGD:6480464 |
CTD |
| G |
Vps52 |
vacuolar protein sorting 52 homolog (S. cerevisiae) |
|
increases expression |
ISO |
20 |
5,073,753 |
5,083,339 |
RGD:6480464 |
CTD |
| G |
Vps53 |
vacuolar protein sorting 53 homolog (S. cerevisiae) |
|
increases expression |
ISO |
10 |
63,410,886 |
63,535,682 |
RGD:6480464 |
CTD |
| G |
Vrk2 |
vaccinia related kinase 2 |
|
decreases expression |
ISO |
14 |
107,287,844 |
107,450,960 |
RGD:6480464 |
CTD |
| G |
Vsx2 |
visual system homeobox 2 |
|
multiple interactions |
EXP |
6 |
108,638,063 |
108,660,830 |
RGD:6480464 |
CTD |
| G |
Vtcn1 |
V-set domain containing T cell activation inhibitor 1 |
|
affects expression |
ISO |
2 |
195,874,348 |
195,942,126 |
RGD:6480464 |
CTD |
| G |
Wap |
whey acidic protein |
|
decreases expression |
EXP |
14 |
87,392,577 |
87,394,669 |
RGD:6480464 |
CTD |
| G |
Wars |
tryptophanyl-tRNA synthetase |
|
decreases expression |
ISO |
6 |
133,200,866 |
133,232,048 |
RGD:6480464 |
CTD |
| G |
Wdr19 |
WD repeat domain 19 |
|
multiple interactions |
ISO |
14 |
45,744,198 |
45,807,441 |
RGD:6480464 |
CTD |
| G |
Wdr19 |
WD repeat domain 19 |
|
decreases expression |
ISO |
14 |
45,744,198 |
45,807,441 |
RGD:6480464 |
CTD |
| G |
Wdr67 |
WD repeat domain 67 |
|
decreases expression |
ISO |
7 |
94,615,000 |
94,676,965 |
RGD:6480464 |
CTD |
| G |
Wdr91 |
WD repeat domain 91 |
|
decreases expression |
ISO |
4 |
62,266,685 |
62,304,007 |
RGD:6480464 |
CTD |
| G |
Wee1 |
wee 1 homolog (S. pombe) |
|
decreases expression |
ISO |
1 |
167,769,797 |
167,788,199 |
RGD:6480464 |
CTD |
| G |
Wfdc6a |
WAP four-disulfide core domain 6A |
|
increases expression |
ISO |
3 |
155,600,267 |
155,604,075 |
RGD:6480464 |
CTD |
| G |
Wfs1 |
Wolfram syndrome 1 (wolframin) |
|
increases expression |
ISO |
14 |
79,379,680 |
79,404,003 |
RGD:6480464 |
CTD |
| G |
Wisp3 |
WNT1 inducible signaling pathway protein 3 |
|
increases expression |
ISO |
20 |
43,297,076 |
43,312,790 |
RGD:6480464 |
CTD |
| G |
Wnt4 |
wingless-type MMTV integration site family, member 4 |
|
multiple interactions |
ISO |
5 |
156,064,371 |
156,083,198 |
RGD:6480464 |
CTD |
| G |
Wnt4 |
wingless-type MMTV integration site family, member 4 |
|
increases expression |
ISO |
5 |
156,064,371 |
156,083,198 |
RGD:6480464 |
CTD |
| G |
Wnt5a |
wingless-type MMTV integration site family, member 5A |
|
decreases expression |
ISO |
16 |
3,782,025 |
3,799,625 |
RGD:6480464 |
CTD |
| G |
Wrnip1 |
Werner helicase interacting protein 1 |
|
decreases expression |
ISO |
17 |
37,982,094 |
38,002,342 |
RGD:6480464 |
CTD |
| G |
Yars |
tyrosyl-tRNA synthetase |
|
decreases expression |
ISO |
5 |
148,350,363 |
148,378,989 |
RGD:6480464 |
CTD |
| G |
Yme1l1 |
YME1-like 1 (S. cerevisiae) |
|
decreases expression |
ISO |
17 |
96,758,634 |
96,796,686 |
RGD:6480464 |
CTD |
| G |
Yod1 |
YOD1 OTU deubiquinating enzyme 1 homolog (S. cerevisiae) |
|
decreases expression |
ISO |
13 |
43,653,274 |
43,654,991 |
RGD:6480464 |
CTD |
| G |
Ypel3 |
yippee-like 3 (Drosophila) |
|
decreases expression |
ISO |
1 |
185,952,796 |
185,956,087 |
RGD:6480464 |
CTD |
| G |
Ypel5 |
yippee-like 5 (Drosophila) |
|
decreases expression |
ISO |
6 |
22,758,416 |
22,773,823 |
RGD:6480464 |
CTD |
| G |
Zbtb32 |
zinc finger and BTB domain containing 32 |
|
increases expression |
ISO |
1 |
85,635,284 |
85,637,589 |
RGD:6480464 |
CTD |
| G |
Zcchc11 |
zinc finger, CCHC domain containing 11 |
|
decreases expression |
ISO |
5 |
129,565,023 |
129,860,103 |
RGD:6480464 |
CTD |
| G |
Zcwpw1 |
zinc finger, CW-type with PWWP domain 1 |
|
increases expression |
ISO |
12 |
19,854,699 |
19,884,804 |
RGD:6480464 |
CTD |
| G |
Zcwpw2 |
zinc finger, CW type with PWWP domain 2 |
|
increases expression |
ISO |
8 |
122,844,355 |
122,940,184 |
RGD:6480464 |
CTD |
| G |
Zfand2a |
zinc finger, AN1-type domain 2A |
|
increases expression |
ISO |
12 |
15,661,609 |
15,672,672 |
RGD:6480464 |
CTD |
| G |
Zfand5 |
zinc finger, AN1-type domain 5 |
|
decreases expression |
ISO |
1 |
224,442,733 |
224,448,701 |
RGD:6480464 |
CTD |
| G |
Zfp36l1 |
zinc finger protein 36, C3H type-like 1 |
|
decreases expression |
ISO |
6 |
103,119,555 |
103,124,576 |
RGD:6480464 |
CTD |
| G |
Zfp655 |
zinc finger protein 655 |
|
decreases expression |
ISO |
12 |
9,670,178 |
9,687,864 |
RGD:6480464 |
CTD |
| G |
Zhx3 |
zinc fingers and homeoboxes 3 |
|
decreases expression |
ISO |
3 |
151,560,440 |
151,574,257 |
RGD:6480464 |
CTD |
| G |
Zim1 |
zinc finger, imprinted 1 |
|
affects expression |
ISO |
1 |
65,535,900 |
65,557,221 |
RGD:6480464 |
CTD |
| G |
Zmym3 |
zinc finger, MYM-type 3 |
|
increases expression |
ISO |
X |
89,476,632 |
89,491,430 |
RGD:6480464 |
CTD |
| G |
Zmynd10 |
zinc finger, MYND-type containing 10 |
|
affects expression |
ISO |
8 |
112,794,227 |
112,798,585 |
RGD:6480464 |
CTD |
| G |
Zmynd8 |
zinc finger, MYND-type containing 8 |
|
decreases expression |
ISO |
3 |
156,860,459 |
156,957,748 |
RGD:6480464 |
CTD |
| G |
Znrf1 |
zinc and ring finger 1, E3 ubiquitin protein ligase |
|
affects expression |
ISO |
19 |
41,455,386 |
41,537,955 |
RGD:6480464 |
CTD |
Term paths to the root
|